[{"categories":["å­¦æœ¯"],"content":"åˆ©ç”¨äººå·¥æ™ºèƒ½åŠ é€Ÿè¯ç‰©ç ”å‘â€”â€”å°åˆ†å­åŠå…¶ä»–é¢†åŸŸ - æ€»ç»“æçº² å‰è¨€ï¼š æœ¬æ¬¡åœ¨çº¿è®²åº§ç”±BioSolveITå…¬å¸ä¸»åŠï¼Œé‚€è¯·äº†ç‘å…¸é˜¿æ–¯åˆ©åº·çš„Eva Nittingeråšå£«ä¸»è®²ã€‚è®²åº§ä¸»é¢˜ä¸º\"åˆ©ç”¨äººå·¥æ™ºèƒ½åŠ é€Ÿè¯ç‰©ç ”å‘â€”â€”å°åˆ†å­åŠå…¶ä»–é¢†åŸŸ\"ã€‚æœ¬æ–‡æ˜¯ç¬”è€…æ•´ç†çš„è®²åº§ç¬”è®°ï¼Œä¾›ä¸­æ–‡ç ”ç©¶è€…å‚è€ƒã€‚ ","date":"2025-06-20","objectID":"/zh-cn/az_seminar-cn/:0:0","tags":["åŒ–å­¦ä¿¡æ¯å­¦"],"title":"ã€è®²åº§ç¬”è®°ã€‘é˜¿æ–¯åˆ©åº·è®¡ç®—æœºè¾…åŠ©è¯ç‰©è®¾è®¡è®²åº§","uri":"/zh-cn/az_seminar-cn/"},{"categories":["å­¦æœ¯"],"content":"1. è¯ç‰©å‘ç°è¿‡ç¨‹æ¦‚è¿° ","date":"2025-06-20","objectID":"/zh-cn/az_seminar-cn/:1:0","tags":["åŒ–å­¦ä¿¡æ¯å­¦"],"title":"ã€è®²åº§ç¬”è®°ã€‘é˜¿æ–¯åˆ©åº·è®¡ç®—æœºè¾…åŠ©è¯ç‰©è®¾è®¡è®²åº§","uri":"/zh-cn/az_seminar-cn/"},{"categories":["å­¦æœ¯"],"content":"1.1 DMTAå¾ªç¯çš„æ ¸å¿ƒåœ°ä½ DMTAå¾ªç¯ï¼šè®¾è®¡(Design) â†’ åˆ¶å¤‡(Make) â†’ æµ‹è¯•(Test) â†’ åˆ†æ(Analyze) æ—¶é—´æŒ‘æˆ˜ï¼šä»åŒ–å­¦èµ·å§‹ç‚¹(hit)åˆ°å€™é€‰è¯ç‰©(CD)éœ€è¦3å¹´ä»¥ä¸Š åŠ é€Ÿç›®æ ‡ï¼šå¦‚ä½•é€šè¿‡è®¡ç®—æ–¹æ³•åŠ é€Ÿè¿™ä¸€è¿‡ç¨‹ ","date":"2025-06-20","objectID":"/zh-cn/az_seminar-cn/:1:1","tags":["åŒ–å­¦ä¿¡æ¯å­¦"],"title":"ã€è®²åº§ç¬”è®°ã€‘é˜¿æ–¯åˆ©åº·è®¡ç®—æœºè¾…åŠ©è¯ç‰©è®¾è®¡è®²åº§","uri":"/zh-cn/az_seminar-cn/"},{"categories":["å­¦æœ¯"],"content":"1.2 è®¡ç®—æœºè¾…åŠ©è¯ç‰©è®¾è®¡çš„å¤æ‚æ€§ ç¡…å†…é¶ç‚¹è¯„ä¼°ï¼š3Dç»“æ„é¢„æµ‹ã€ç»“åˆæ¨¡å¼ã€æ¨¡å¼é€‰æ‹© åŒ–å­¦ç©ºé—´æ¢ç´¢ï¼šå‘½ä¸­è¯†åˆ«ã€åŒ–å­¦ç³»åˆ—é€‰æ‹©ã€çŸ¥è¯†äº§æƒåˆ†æ åŒ–åˆç‰©è°±ä¼˜åŒ–ï¼šå¤šå‚æ•°(\u003e100)ä¼˜åŒ–ã€å¹³è¡¡ç›¸äº’å…³è”å’Œå¯¹ç«‹å› ç´  ","date":"2025-06-20","objectID":"/zh-cn/az_seminar-cn/:1:2","tags":["åŒ–å­¦ä¿¡æ¯å­¦"],"title":"ã€è®²åº§ç¬”è®°ã€‘é˜¿æ–¯åˆ©åº·è®¡ç®—æœºè¾…åŠ©è¯ç‰©è®¾è®¡è®²åº§","uri":"/zh-cn/az_seminar-cn/"},{"categories":["å­¦æœ¯"],"content":"2. è›‹ç™½è´¨æŠ˜å ä¸ç»“æ„é¢„æµ‹ ","date":"2025-06-20","objectID":"/zh-cn/az_seminar-cn/:2:0","tags":["åŒ–å­¦ä¿¡æ¯å­¦"],"title":"ã€è®²åº§ç¬”è®°ã€‘é˜¿æ–¯åˆ©åº·è®¡ç®—æœºè¾…åŠ©è¯ç‰©è®¾è®¡è®²åº§","uri":"/zh-cn/az_seminar-cn/"},{"categories":["å­¦æœ¯"],"content":"2.1 AlphaFoldçš„æˆåŠŸåº”ç”¨æ¡ˆä¾‹ åˆ†å­æ›¿æ¢æ¨¡æ¿ï¼šXå°„çº¿æ™¶ä½“å­¦ä¸­çš„åº”ç”¨ åŠŸèƒ½é¢„æµ‹ï¼šé€šè¿‡é¢„æµ‹æ•°æ®è¡¥å……å®éªŒæ•°æ® ç»“æ„åŠ¨åŠ›å­¦ï¼šæ¢ç´¢AlphaFoldæ˜¯å¦èƒ½é¢„æµ‹è›‹ç™½è´¨åŠ¨æ€å˜åŒ– ","date":"2025-06-20","objectID":"/zh-cn/az_seminar-cn/:2:1","tags":["åŒ–å­¦ä¿¡æ¯å­¦"],"title":"ã€è®²åº§ç¬”è®°ã€‘é˜¿æ–¯åˆ©åº·è®¡ç®—æœºè¾…åŠ©è¯ç‰©è®¾è®¡è®²åº§","uri":"/zh-cn/az_seminar-cn/"},{"categories":["å­¦æœ¯"],"content":"2.2 ç»“æ„é¢„æµ‹æ–¹æ³•çš„å±€é™æ€§ ä¼˜åŠ¿é¢†åŸŸï¼š å•ä¸€ç»“æ„è§£æ å¼ºè›‹ç™½è´¨-è›‹ç™½è´¨ç›¸äº’ä½œç”¨ ä¸é€‚ç”¨é¢†åŸŸï¼š åŠ¨æ€å’Œç»“æ„è¿åŠ¨ æ–°å‹æ¨¡å¼(å¦‚PROTACs) ","date":"2025-06-20","objectID":"/zh-cn/az_seminar-cn/:2:2","tags":["åŒ–å­¦ä¿¡æ¯å­¦"],"title":"ã€è®²åº§ç¬”è®°ã€‘é˜¿æ–¯åˆ©åº·è®¡ç®—æœºè¾…åŠ©è¯ç‰©è®¾è®¡è®²åº§","uri":"/zh-cn/az_seminar-cn/"},{"categories":["å­¦æœ¯"],"content":"2.3 æ·±åº¦å­¦ä¹ æ–¹æ³•æ¯”è¾ƒ å¤šç§æ–¹æ³•è¯„ä¼°ï¼šAlphaFold2ã€RoseTTAFoldã€NeuralPlexerç­‰ ç»“åˆçŠ¶æ€é¢„æµ‹ï¼šå¼€æ”¾æ€(apo)vsé—­åˆæ€(holo)ç»“æ„é¢„æµ‹ åå·®åˆ†æï¼šNeuralPlexerå’ŒRoseTTAFoldåœ¨é…ä½“ä¿¡æ¯è·å–æ–¹é¢çš„ä¼˜åŠ¿ ","date":"2025-06-20","objectID":"/zh-cn/az_seminar-cn/:2:3","tags":["åŒ–å­¦ä¿¡æ¯å­¦"],"title":"ã€è®²åº§ç¬”è®°ã€‘é˜¿æ–¯åˆ©åº·è®¡ç®—æœºè¾…åŠ©è¯ç‰©è®¾è®¡è®²åº§","uri":"/zh-cn/az_seminar-cn/"},{"categories":["å­¦æœ¯"],"content":"3. åŒ–å­¦ç©ºé—´æ¢ç´¢ä¸åˆ©ç”¨ ","date":"2025-06-20","objectID":"/zh-cn/az_seminar-cn/:3:0","tags":["åŒ–å­¦ä¿¡æ¯å­¦"],"title":"ã€è®²åº§ç¬”è®°ã€‘é˜¿æ–¯åˆ©åº·è®¡ç®—æœºè¾…åŠ©è¯ç‰©è®¾è®¡è®²åº§","uri":"/zh-cn/az_seminar-cn/"},{"categories":["å­¦æœ¯"],"content":"3.1 ç”Ÿæˆå¼å»ºæ¨¡ vs è™šæ‹Ÿç­›é€‰ ä¼ ç»Ÿè™šæ‹Ÿç­›é€‰ï¼š åœ¨å¤§å‹æ•°æ®åº“ä¸­æœç´¢ï¼Œå¯»æ‰¾å°‘é‡åˆé€‚çš„å‘½ä¸­åŒ–åˆç‰© ç±»ä¼¼\"å¤§æµ·æé’ˆ\"çš„è¿‡ç¨‹ ç”Ÿæˆå¼æ¨¡å‹ï¼š ä»¥æ¦‚ç‡æ–¹å¼ç¼–ç å‡ ä¹æ— é™çš„åŒ–å­¦ç©ºé—´ æ›´é«˜æ•ˆçš„åŒ–å­¦ç©ºé—´æ¢ç´¢ ","date":"2025-06-20","objectID":"/zh-cn/az_seminar-cn/:3:1","tags":["åŒ–å­¦ä¿¡æ¯å­¦"],"title":"ã€è®²åº§ç¬”è®°ã€‘é˜¿æ–¯åˆ©åº·è®¡ç®—æœºè¾…åŠ©è¯ç‰©è®¾è®¡è®²åº§","uri":"/zh-cn/az_seminar-cn/"},{"categories":["å­¦æœ¯"],"content":"3.2 åŒ–åˆç‰©ç›¸ä¼¼æ€§åˆ†æ è¿‘é‚»åˆ†æï¼šåŒ–åˆç‰©æ‹¥æœ‰å¤šå°‘ä¸ªè¿‘é‚»ï¼Ÿ é‡‡æ ·ç­–ç•¥å¯¹æ¯”ï¼šé»˜è®¤ã€å¼ºåŒ–å­¦ä¹ ã€å¤šé¡¹å¼ã€é›†æŸæœç´¢ æ€§èƒ½è¯„ä¼°ï¼šé€šè¿‡REINVENTç­‰æ–¹æ³•è¿›è¡Œå®é™…åº”ç”¨éªŒè¯ ","date":"2025-06-20","objectID":"/zh-cn/az_seminar-cn/:3:2","tags":["åŒ–å­¦ä¿¡æ¯å­¦"],"title":"ã€è®²åº§ç¬”è®°ã€‘é˜¿æ–¯åˆ©åº·è®¡ç®—æœºè¾…åŠ©è¯ç‰©è®¾è®¡è®²åº§","uri":"/zh-cn/az_seminar-cn/"},{"categories":["å­¦æœ¯"],"content":"3.3 åŒ–å­¦ç©ºé—´çš„è§„æ¨¡å’Œå¤šæ ·æ€§ æ•°æ®æ¥æºï¼šåŸºäº26ä¸ªAZå†…éƒ¨é¡¹ç›®çš„å›é¡¾æ€§åˆ†æ ç»™è¯é€”å¾„ï¼šå£æœç»™è¯åˆ†æ å…³é”®å‚æ•°ï¼šlogDã€æº¶è§£æ€§ã€æ¸…é™¤ç‡çš„åˆ†æ ","date":"2025-06-20","objectID":"/zh-cn/az_seminar-cn/:3:3","tags":["åŒ–å­¦ä¿¡æ¯å­¦"],"title":"ã€è®²åº§ç¬”è®°ã€‘é˜¿æ–¯åˆ©åº·è®¡ç®—æœºè¾…åŠ©è¯ç‰©è®¾è®¡è®²åº§","uri":"/zh-cn/az_seminar-cn/"},{"categories":["å­¦æœ¯"],"content":"4. åŒ–åˆç‰©ä¼˜åŒ–ä¸åˆ†å­è®¾è®¡ ","date":"2025-06-20","objectID":"/zh-cn/az_seminar-cn/:4:0","tags":["åŒ–å­¦ä¿¡æ¯å­¦"],"title":"ã€è®²åº§ç¬”è®°ã€‘é˜¿æ–¯åˆ©åº·è®¡ç®—æœºè¾…åŠ©è¯ç‰©è®¾è®¡è®²åº§","uri":"/zh-cn/az_seminar-cn/"},{"categories":["å­¦æœ¯"],"content":"4.1 åˆ†å­æ„æ€ä¸åŒ–åˆç‰©ä¼˜å…ˆçº§æ’åº æŒ‘æˆ˜ï¼šå¦‚ä½•è¿‡æ»¤å’Œé€‰æ‹©ï¼Ÿ å¤šç§ç­–ç•¥ï¼š Xå°„çº¿æ¨¡å‹å¯Œé›†å¯¹æ¥å¾—åˆ† åˆ†å­åŠ¨åŠ›å­¦æ¢ç´¢FEPé¢„æµ‹äº²å’ŒåŠ› QSARæ’å€¼é¢„æµ‹æ´»æ€§ ","date":"2025-06-20","objectID":"/zh-cn/az_seminar-cn/:4:1","tags":["åŒ–å­¦ä¿¡æ¯å­¦"],"title":"ã€è®²åº§ç¬”è®°ã€‘é˜¿æ–¯åˆ©åº·è®¡ç®—æœºè¾…åŠ©è¯ç‰©è®¾è®¡è®²åº§","uri":"/zh-cn/az_seminar-cn/"},{"categories":["å­¦æœ¯"],"content":"4.2 QSARæ–¹æ³•çš„å‡è®¾ä¸å±€é™ åŸºæœ¬å‡è®¾ï¼š ç›¸ä¼¼æ€§åŸç†ï¼šâ€œç»“æ„ç›¸ä¼¼çš„åŒ–åˆç‰©å…·æœ‰ç›¸ä¼¼çš„æ´»æ€§â€ çº¿æ€§å’ŒåŠ æ€§ï¼šåŒ–å­¦ç©ºé—´ä¸­çš„çº¿æ€§å…³ç³» å¤–æ¨å‰æï¼šä»å·²çŸ¥æ•°æ®é¢„æµ‹æœªçŸ¥æ•°æ® ä¸»è¦å±€é™ï¼š éåŠ æ€§é—®é¢˜ï¼šRÂ²å’ŒRMSEåœ¨éåŠ æ€§æ•°æ®ä¸Šè¡¨ç°æ˜¾è‘—è¾ƒå·® æ•°æ®ä¾èµ–æ€§ï¼šå…¬å…±æ•°æ®(5.1%)å’Œå†…éƒ¨æ•°æ®(9.4%)ä¸­å­˜åœ¨æ˜¾è‘—çš„NAå€¼ æ¨¡å‹æ„å»ºé‡è¦æ€§ï¼šæ£€æµ‹éçº¿æ€§å¯¹è¿›ä¸€æ­¥ä½¿ç”¨è‡³å…³é‡è¦ ","date":"2025-06-20","objectID":"/zh-cn/az_seminar-cn/:4:2","tags":["åŒ–å­¦ä¿¡æ¯å­¦"],"title":"ã€è®²åº§ç¬”è®°ã€‘é˜¿æ–¯åˆ©åº·è®¡ç®—æœºè¾…åŠ©è¯ç‰©è®¾è®¡è®²åº§","uri":"/zh-cn/az_seminar-cn/"},{"categories":["å­¦æœ¯"],"content":"4.3 æ·±åº¦å­¦ä¹ å¯¹æ¥ vs ç»å…¸æ–¹æ³• æ–¹æ³•æ¯”è¾ƒï¼šDeepDockã€Uni-Molã€DiffDockã€EquiBindã€TankBind éªŒè¯æ ‡å‡†ï¼šPoseBusterè´¨é‡æ£€æŸ¥ã€åŒ–å­¦æœ‰æ•ˆæ€§ã€åˆ†å­å†…å’Œåˆ†å­é—´æœ‰æ•ˆæ€§ ç»“è®ºï¼šDLæ–¹æ³•æœªèƒ½è¶…è¶Šç»å…¸å¯¹æ¥æ–¹æ³• ","date":"2025-06-20","objectID":"/zh-cn/az_seminar-cn/:4:3","tags":["åŒ–å­¦ä¿¡æ¯å­¦"],"title":"ã€è®²åº§ç¬”è®°ã€‘é˜¿æ–¯åˆ©åº·è®¡ç®—æœºè¾…åŠ©è¯ç‰©è®¾è®¡è®²åº§","uri":"/zh-cn/az_seminar-cn/"},{"categories":["å­¦æœ¯"],"content":"5. æ–°å‹æ¨¡å¼ï¼šPROTACæŠ€æœ¯ ","date":"2025-06-20","objectID":"/zh-cn/az_seminar-cn/:5:0","tags":["åŒ–å­¦ä¿¡æ¯å­¦"],"title":"ã€è®²åº§ç¬”è®°ã€‘é˜¿æ–¯åˆ©åº·è®¡ç®—æœºè¾…åŠ©è¯ç‰©è®¾è®¡è®²åº§","uri":"/zh-cn/az_seminar-cn/"},{"categories":["å­¦æœ¯"],"content":"5.1 PROTACå·¥ä½œæœºåˆ¶ ä¸‰å…ƒå¤åˆç‰©å½¢æˆï¼šE3è¿æ¥é…¶ + PROTACåˆ†å­ + ç›®æ ‡è›‹ç™½(POI) é™è§£è¿‡ç¨‹ï¼šPOIæ³›ç´ åŒ– â†’ è›‹ç™½é…¶ä½“é™è§£ ä¼˜åŠ¿ï¼šé’ˆå¯¹\"ä¸å¯è¯åŒ–\"é¶ç‚¹çš„æ–°ç­–ç•¥ ","date":"2025-06-20","objectID":"/zh-cn/az_seminar-cn/:5:1","tags":["åŒ–å­¦ä¿¡æ¯å­¦"],"title":"ã€è®²åº§ç¬”è®°ã€‘é˜¿æ–¯åˆ©åº·è®¡ç®—æœºè¾…åŠ©è¯ç‰©è®¾è®¡è®²åº§","uri":"/zh-cn/az_seminar-cn/"},{"categories":["å­¦æœ¯"],"content":"5.2 PROTACä¸‰å…ƒå¤åˆç‰©é¢„æµ‹ ç ”ç©¶è®¾ç½®ï¼š æ•°æ®é›†ï¼š9ä¸ªPROTACä¸‰å…ƒå¤åˆç‰© åºåˆ—é€‰æ‹©ï¼šæ™¶ä½“ç»“æ„(~130æ°¨åŸºé…¸) vs å…¨é•¿åºåˆ—(1647æ°¨åŸºé…¸) é¢„æµ‹æŒ‘æˆ˜ï¼šåŸºäºE3å’ŒPOIé¢„æµ‹ï¼Œæ— PROTACåˆ†å­æœ¬èº«ä¿¡æ¯ é¢„æµ‹ç»“æœåˆ†æï¼š å…¨é•¿åºåˆ—ï¼šE3å’ŒPOIä¹‹é—´æ— é¢„æµ‹æ¥è§¦ æ™¶ä½“åºåˆ—ï¼šæ­£ç¡®é¢„æµ‹ä¸ªåˆ«è›‹ç™½è´¨ï¼Œä½†E3å’ŒPOIç›¸å¯¹ä½ç½®ä¸æ­£ç¡® äººå·¥è¿æ¥ï¼šé™ä½ç»“æ„å˜å¼‚ï¼Œä½†ç›¸å¯¹/æ—‹è½¬å®šä½ä»ä¸æ­£ç¡® ","date":"2025-06-20","objectID":"/zh-cn/az_seminar-cn/:5:2","tags":["åŒ–å­¦ä¿¡æ¯å­¦"],"title":"ã€è®²åº§ç¬”è®°ã€‘é˜¿æ–¯åˆ©åº·è®¡ç®—æœºè¾…åŠ©è¯ç‰©è®¾è®¡è®²åº§","uri":"/zh-cn/az_seminar-cn/"},{"categories":["å­¦æœ¯"],"content":"5.3 ç»“æ„é¢„æµ‹æ–¹æ³•çš„è¿›ä¸€æ­¥ç»“è®º ä¸é€‚ç”¨åœºæ™¯ï¼š åŠ¨æ€å’Œç»“æ„è¿åŠ¨ æ–°å‹æ¨¡å¼(å¦‚PROTACs) éœ€è¦è¾…åŠ©æŠ˜å æ”¹å–„é¢„æµ‹ æ”¹è¿›æ–¹å‘ï¼š AF2 â†’ AF3ï¼šæŸäº›æ”¹å–„ä½†ä¸ä¸€è‡´ AF3^multimer â†’ AF3^16ï¼šå¤šæ•°æƒ…å†µä¸‹æœ‰æ”¹å–„ ","date":"2025-06-20","objectID":"/zh-cn/az_seminar-cn/:5:3","tags":["åŒ–å­¦ä¿¡æ¯å­¦"],"title":"ã€è®²åº§ç¬”è®°ã€‘é˜¿æ–¯åˆ©åº·è®¡ç®—æœºè¾…åŠ©è¯ç‰©è®¾è®¡è®²åº§","uri":"/zh-cn/az_seminar-cn/"},{"categories":["å­¦æœ¯"],"content":"6. é™è§£æ•ˆç‡å»ºæ¨¡ ","date":"2025-06-20","objectID":"/zh-cn/az_seminar-cn/:6:0","tags":["åŒ–å­¦ä¿¡æ¯å­¦"],"title":"ã€è®²åº§ç¬”è®°ã€‘é˜¿æ–¯åˆ©åº·è®¡ç®—æœºè¾…åŠ©è¯ç‰©è®¾è®¡è®²åº§","uri":"/zh-cn/az_seminar-cn/"},{"categories":["å­¦æœ¯"],"content":"6.1 æ•°æ®é›†æ„å»º PROTAC-DBæ•°æ®ï¼šåŒ…å«ç‹¬ç‰¹SMILESã€ç‹¬ç‰¹é¶ç‚¹ã€å…±äº«SMILESçš„ç»¼åˆæ•°æ®åº“ æ•°æ®å¤„ç†æµç¨‹ï¼šæ­£åˆ™è¡¨è¾¾å¼ â†’ åˆå¹¶ â†’ æ ‡å‡†åŒ–ç»†èƒç³»å’ŒE3é…ä½“ â†’ åº”ç”¨è¿‡æ»¤å™¨å’Œå®šä¹‰ ","date":"2025-06-20","objectID":"/zh-cn/az_seminar-cn/:6:1","tags":["åŒ–å­¦ä¿¡æ¯å­¦"],"title":"ã€è®²åº§ç¬”è®°ã€‘é˜¿æ–¯åˆ©åº·è®¡ç®—æœºè¾…åŠ©è¯ç‰©è®¾è®¡è®²åº§","uri":"/zh-cn/az_seminar-cn/"},{"categories":["å­¦æœ¯"],"content":"6.2 æœºå™¨å­¦ä¹ æ¨¡å‹æ¶æ„ è¾“å…¥ç‰¹å¾ï¼šPROTAC SMILESã€POI UniProt IDã€E3é…ä½“IDã€ç»†èƒç³»åç§° æ¨¡å‹ç»„ä»¶ï¼šMorgan FPç”Ÿæˆå™¨ã€Bio-Emb T5æ¨¡å‹ã€One-hotç¼–ç å™¨ è¶…å‚æ•°ä¼˜åŒ–ï¼šä½¿ç”¨Optunaè¿›è¡Œä¼˜åŒ– ","date":"2025-06-20","objectID":"/zh-cn/az_seminar-cn/:6:2","tags":["åŒ–å­¦ä¿¡æ¯å­¦"],"title":"ã€è®²åº§ç¬”è®°ã€‘é˜¿æ–¯åˆ©åº·è®¡ç®—æœºè¾…åŠ©è¯ç‰©è®¾è®¡è®²åº§","uri":"/zh-cn/az_seminar-cn/"},{"categories":["å­¦æœ¯"],"content":"6.3 æ¨¡å‹æ€§èƒ½è¯„ä¼° æ•°æ®æ‹†åˆ†ç­–ç•¥ï¼šæ ‡å‡†åˆ†å‰²ã€ç›¸ä¼¼æ€§åˆ†å‰²ã€é¶ç‚¹åˆ†å‰² è¯„ä¼°æŒ‡æ ‡ï¼šéªŒè¯å‡†ç¡®ç‡ã€æµ‹è¯•å‡†ç¡®ç‡ã€ROC AUC æ¶ˆèç ”ç©¶ï¼šç¡®å®šå„æ¶æ„ç»„ä»¶çš„é‡è¦æ€§ ","date":"2025-06-20","objectID":"/zh-cn/az_seminar-cn/:6:3","tags":["åŒ–å­¦ä¿¡æ¯å­¦"],"title":"ã€è®²åº§ç¬”è®°ã€‘é˜¿æ–¯åˆ©åº·è®¡ç®—æœºè¾…åŠ©è¯ç‰©è®¾è®¡è®²åº§","uri":"/zh-cn/az_seminar-cn/"},{"categories":["å­¦æœ¯"],"content":"7. æœªæ¥å‘å±•æ–¹å‘ ","date":"2025-06-20","objectID":"/zh-cn/az_seminar-cn/:7:0","tags":["åŒ–å­¦ä¿¡æ¯å­¦"],"title":"ã€è®²åº§ç¬”è®°ã€‘é˜¿æ–¯åˆ©åº·è®¡ç®—æœºè¾…åŠ©è¯ç‰©è®¾è®¡è®²åº§","uri":"/zh-cn/az_seminar-cn/"},{"categories":["å­¦æœ¯"],"content":"7.1 æŠ€æœ¯æŒ‘æˆ˜ ç”Ÿæˆå‡†ç¡®çš„ä¸‰å…ƒç»“æ„ï¼šä»æ˜¯å¼€æ”¾æ€§æŒ‘æˆ˜ è¾…åŠ©æŠ˜å æ½œåŠ›ï¼šæ˜¯å¦èƒ½æ”¹å–„é¢„æµ‹æ•ˆæœï¼Ÿ PROTACsplitterå¼€å‘ï¼šä¸ºPROTACé™è§£é¢„æµ‹æä¾›ä¿¡æ¯ ","date":"2025-06-20","objectID":"/zh-cn/az_seminar-cn/:7:1","tags":["åŒ–å­¦ä¿¡æ¯å­¦"],"title":"ã€è®²åº§ç¬”è®°ã€‘é˜¿æ–¯åˆ©åº·è®¡ç®—æœºè¾…åŠ©è¯ç‰©è®¾è®¡è®²åº§","uri":"/zh-cn/az_seminar-cn/"},{"categories":["å­¦æœ¯"],"content":"7.2 å®é™…åº”ç”¨è€ƒé‡ ç°å®é—®é¢˜ï¼š ç”Ÿæˆæ¨¡å‹ä¼˜åŠ¿ï¼šåœ¨æ–°åŒ–åˆç‰©å‘ç°æ–¹é¢è¡¨ç°è‰¯å¥½ é«˜é€šé‡å¯¹æ¥é™åˆ¶ï¼šç»“æ„æŸ”æ€§ä»æ˜¯é—®é¢˜ ç­›é€‰è¿‡ç¨‹æŒ‘æˆ˜ï¼šéœ€è¦æ­£ç¡®è¯†åˆ«å’Œé¢„æµ‹åŒ–åˆç‰©æ€§è´¨ æ•°æ®å’Œæ¨¡å‹æ”¹è¿›ï¼š æ›´å¥½çš„æ¨¡å‹å’Œæ›´å¥½çš„æ•°æ®æ˜¯å…³é”® éåŠ æ€§ä½œä¸ºé¢„æµ‹ç›®æ ‡ï¼šè¯†åˆ«å’Œé¢„æµ‹éåŠ æ€§è¡Œä¸º æ¡ˆä¾‹ä¾èµ–æ€§ï¼šç›®å‰ä»ç„¶é«˜åº¦ä¾èµ–å…·ä½“æ¡ˆä¾‹ï¼Œç¼ºä¹æ ‡å‡†åŒ–è§£å†³æ–¹æ¡ˆ ","date":"2025-06-20","objectID":"/zh-cn/az_seminar-cn/:7:2","tags":["åŒ–å­¦ä¿¡æ¯å­¦"],"title":"ã€è®²åº§ç¬”è®°ã€‘é˜¿æ–¯åˆ©åº·è®¡ç®—æœºè¾…åŠ©è¯ç‰©è®¾è®¡è®²åº§","uri":"/zh-cn/az_seminar-cn/"},{"categories":["å­¦æœ¯"],"content":"8. æ€»ç»“ï¼šç‚’ä½œè¿˜æ˜¯ç°å®ï¼Ÿ ","date":"2025-06-20","objectID":"/zh-cn/az_seminar-cn/:8:0","tags":["åŒ–å­¦ä¿¡æ¯å­¦"],"title":"ã€è®²åº§ç¬”è®°ã€‘é˜¿æ–¯åˆ©åº·è®¡ç®—æœºè¾…åŠ©è¯ç‰©è®¾è®¡è®²åº§","uri":"/zh-cn/az_seminar-cn/"},{"categories":["å­¦æœ¯"],"content":"8.1 æŠ€æœ¯ç°çŠ¶è¯„ä¼° ç”Ÿæˆæ¨¡å‹ï¼šåœ¨æ–°åŒ–åˆç‰©å‘ç°æ–¹é¢ç¡®å®æœ‰æ•ˆ ç»“æ„é¢„æµ‹ï¼šé«˜é€šé‡å¯¹æ¥å’Œç»“æ„æŸ”æ€§ä»æœ‰é—®é¢˜ å®é™…åº”ç”¨ï¼šç­›é€‰è¿‡ç¨‹éœ€è¦æ­£ç¡®çš„åŒ–åˆç‰©æ€§è´¨è¯†åˆ«å’Œé¢„æµ‹ ","date":"2025-06-20","objectID":"/zh-cn/az_seminar-cn/:8:1","tags":["åŒ–å­¦ä¿¡æ¯å­¦"],"title":"ã€è®²åº§ç¬”è®°ã€‘é˜¿æ–¯åˆ©åº·è®¡ç®—æœºè¾…åŠ©è¯ç‰©è®¾è®¡è®²åº§","uri":"/zh-cn/az_seminar-cn/"},{"categories":["å­¦æœ¯"],"content":"8.2 å…³é”®æˆåŠŸå› ç´  æ•°æ®è´¨é‡ï¼šæ›´å¥½çš„æ•°æ®æ˜¯åŸºç¡€ æ¨¡å‹æ”¹è¿›ï¼šæŒç»­çš„ç®—æ³•å’Œæ–¹æ³•å­¦åˆ›æ–° éåŠ æ€§é¢„æµ‹ï¼šä½œä¸ºç†æƒ³çš„é¢„æµ‹å’Œè¯†åˆ«äº‹ä»¶ æ ‡å‡†åŒ–éœ€æ±‚ï¼šç›®å‰ä»ç„¶é«˜åº¦ä¾èµ–æ¡ˆä¾‹ï¼Œç¼ºä¹é€šç”¨è§£å†³æ–¹æ¡ˆ æ ¸å¿ƒç»“è®ºï¼šè™½ç„¶AIåœ¨è¯ç‰©å‘ç°é¢†åŸŸå±•ç°å‡ºå·¨å¤§æ½œåŠ›ï¼Œä½†å½“å‰æŠ€æœ¯ä»é¢ä¸´æ˜¾è‘—æŒ‘æˆ˜ã€‚æˆåŠŸçš„å…³é”®åœ¨äºç»“åˆæ›´å¥½çš„æ•°æ®ã€æ”¹è¿›çš„æ¨¡å‹ä»¥åŠå¯¹æ–¹æ³•å±€é™æ€§çš„æ¸…æ™°è®¤è¯†ã€‚ç‰¹åˆ«æ˜¯åœ¨PROTACç­‰æ–°å…´æ²»ç–—æ¨¡å¼æ–¹é¢ï¼Œä»éœ€è¦å¤§é‡çš„æŠ€æœ¯åˆ›æ–°å’Œæ–¹æ³•å­¦çªç ´ã€‚ ","date":"2025-06-20","objectID":"/zh-cn/az_seminar-cn/:8:2","tags":["åŒ–å­¦ä¿¡æ¯å­¦"],"title":"ã€è®²åº§ç¬”è®°ã€‘é˜¿æ–¯åˆ©åº·è®¡ç®—æœºè¾…åŠ©è¯ç‰©è®¾è®¡è®²åº§","uri":"/zh-cn/az_seminar-cn/"},{"categories":["åŸºç¡€çŸ¥è¯†","è¯¾ç¨‹"],"content":"Advanced Molecular Modelling Applied to Drug Discovery(3FK181)ï¼ŒUppsala University Exam Preparation Notes- 2023 ","date":"2025-03-28","objectID":"/zh-cn/advanced-modelling/:0:0","tags":["åŒ–å­¦ä¿¡æ¯å­¦","è®¡ç®—è¯ç‰©åŒ–å­¦","Pharameutical Modelling"],"title":"ä¹Œæ™®è¨æ‹‰å¤§å­¦ Advanced Molecular Modelling Applied to Drug Discovery(3FK181) è¯¾ç¨‹å¤ä¹ ç¬”è®°","uri":"/zh-cn/advanced-modelling/"},{"categories":["åŸºç¡€çŸ¥è¯†","è¯¾ç¨‹"],"content":"Note è¿™æ˜¯ä¸€ä¸ªä¸ªäººçš„å¤‡è€ƒå¤ä¹ ç¬”è®°ï¼Œé€‚ç”¨äºç‘å…¸ğŸ‡¸ğŸ‡ªä¹Œæ™®è¨æ‹‰å¤§å­¦çš„è¯¾ç¨‹ Advanced Molecular Modelling Applied to Drug Discovery(3FK181)ï¼ŒUppsala University.æ‰‹å†™ç¬”è®°ç”± Claude AIè½¬æ¢ä¸ºMarkdownæ ¼å¼ï¼Œ ä»…ä¾›å‚è€ƒã€‚ åŸå§‹æ–‡æ¡£å¯ç‚¹å‡»è¿™é‡Œä¸‹è½½ ","date":"2025-03-28","objectID":"/zh-cn/advanced-modelling/:1:0","tags":["åŒ–å­¦ä¿¡æ¯å­¦","è®¡ç®—è¯ç‰©åŒ–å­¦","Pharameutical Modelling"],"title":"ä¹Œæ™®è¨æ‹‰å¤§å­¦ Advanced Molecular Modelling Applied to Drug Discovery(3FK181) è¯¾ç¨‹å¤ä¹ ç¬”è®°","uri":"/zh-cn/advanced-modelling/"},{"categories":["åŸºç¡€çŸ¥è¯†","è¯¾ç¨‹"],"content":"Chapter 1: Ligand-Protein Interaction ","date":"2025-03-28","objectID":"/zh-cn/advanced-modelling/:2:0","tags":["åŒ–å­¦ä¿¡æ¯å­¦","è®¡ç®—è¯ç‰©åŒ–å­¦","Pharameutical Modelling"],"title":"ä¹Œæ™®è¨æ‹‰å¤§å­¦ Advanced Molecular Modelling Applied to Drug Discovery(3FK181) è¯¾ç¨‹å¤ä¹ ç¬”è®°","uri":"/zh-cn/advanced-modelling/"},{"categories":["åŸºç¡€çŸ¥è¯†","è¯¾ç¨‹"],"content":"Key Points: Describing the interaction of molecules Determining if a molecule is a good target or not Types of Interactions: Electrostatics: Follow Coulombâ€™s Law F = -qâ‚qâ‚‚/4Ï€Îµâ‚€rÂ² (Îµâ‚€: electric constant, qâ‚, qâ‚‚: charges) Ï€-Ï€ stacking: interactions between benzene rings Ï€-cation interactions: e.g., AchE with -NHâ‚ƒâº and -Ph groups H-bond: Consider O, N atoms Mention HBD (hydrogen bond donors): -OH, -NHâ‚‚ HBA (hydrogen bond acceptors): C=O, Câ‰¡N (æœ‰ä¾›æ°¢çš„) Halogen bond: ClÂ·Â·Â·O, BrÂ·Â·Â·O, IÂ·Â·Â·O No F bonds; if there is a -OFâ‚ƒ group, it shows hydrophobic effect Polarization: Charge redistribution when molecules approach each other Charge â†’ Dipole Dipole â†’ Dipole Dipole-Dipole Interaction â†’ Polarization â†’ London Dispersion Not generally included in molecular mechanics London Dispersion: Dispersive forces (è‰²æ•£åŠ›) Ï€-stacking interactions Covalent Bond: Advantages: Potency Selectivity PD (Pharmacodynamics) Risks: Toxicity Explanation: Potency: Interaction is irreversible, very stable Selectivity: Can interact with specific proteins Afatinib: Irreversibly binds certain proteins PD: Not requiring high blood concentration; takes a long time Toxicity: Off-target effects, irreversible Hydrophobic effect: An entropic effect (ç†µçš„) Gains potency but reduces solubility Order of the dynamic hydrogen bond in water to accommodate a non-polar solute Considerations for L-P (Ligand-Protein) interaction: Size Shape Exposure (æš´éœ²å¤–è¡¨çš„æ™¯è±¡) Hydrophilic/Hydrophobic properties Ligandability/Druggability Flexibility Relative Strength of Interactions: Covalent \u003e Electrostatic \u003e H-bond \u003e van der Waals åŠ›çš„ä½œç”¨åŠ›å¤§å° ","date":"2025-03-28","objectID":"/zh-cn/advanced-modelling/:2:1","tags":["åŒ–å­¦ä¿¡æ¯å­¦","è®¡ç®—è¯ç‰©åŒ–å­¦","Pharameutical Modelling"],"title":"ä¹Œæ™®è¨æ‹‰å¤§å­¦ Advanced Molecular Modelling Applied to Drug Discovery(3FK181) è¯¾ç¨‹å¤ä¹ ç¬”è®°","uri":"/zh-cn/advanced-modelling/"},{"categories":["åŸºç¡€çŸ¥è¯†","è¯¾ç¨‹"],"content":"Chapter 2: Molecular Dynamic Simulation ","date":"2025-03-28","objectID":"/zh-cn/advanced-modelling/:3:0","tags":["åŒ–å­¦ä¿¡æ¯å­¦","è®¡ç®—è¯ç‰©åŒ–å­¦","Pharameutical Modelling"],"title":"ä¹Œæ™®è¨æ‹‰å¤§å­¦ Advanced Molecular Modelling Applied to Drug Discovery(3FK181) è¯¾ç¨‹å¤ä¹ ç¬”è®°","uri":"/zh-cn/advanced-modelling/"},{"categories":["åŸºç¡€çŸ¥è¯†","è¯¾ç¨‹"],"content":"I. Why Simulation Study larger biological systems Calculate movement as a function of time Predict and explain outcomes of biological experiments Example: Butane (ä¸çƒ·) conformational analysis â†’ Peptide folding ","date":"2025-03-28","objectID":"/zh-cn/advanced-modelling/:3:1","tags":["åŒ–å­¦ä¿¡æ¯å­¦","è®¡ç®—è¯ç‰©åŒ–å­¦","Pharameutical Modelling"],"title":"ä¹Œæ™®è¨æ‹‰å¤§å­¦ Advanced Molecular Modelling Applied to Drug Discovery(3FK181) è¯¾ç¨‹å¤ä¹ ç¬”è®°","uri":"/zh-cn/advanced-modelling/"},{"categories":["åŸºç¡€çŸ¥è¯†","è¯¾ç¨‹"],"content":"II. Molecular Mechanics Approximation Ignore electron motion Born-Oppenheimer approximation: Separate electron and nuclear movements Use Newtonâ€™s laws to describe the system Apply small molecule parameters to larger systems ","date":"2025-03-28","objectID":"/zh-cn/advanced-modelling/:3:2","tags":["åŒ–å­¦ä¿¡æ¯å­¦","è®¡ç®—è¯ç‰©åŒ–å­¦","Pharameutical Modelling"],"title":"ä¹Œæ™®è¨æ‹‰å¤§å­¦ Advanced Molecular Modelling Applied to Drug Discovery(3FK181) è¯¾ç¨‹å¤ä¹ ç¬”è®°","uri":"/zh-cn/advanced-modelling/"},{"categories":["åŸºç¡€çŸ¥è¯†","è¯¾ç¨‹"],"content":"III. Van der Waals Force Repulsive then attractive UVdW = 4Îµ[(Ïƒ/r)Â¹Â² - (Ïƒ/r)â¶] Ïƒ: Collision diameter Îµ: Well depth Non-bonded interaction ","date":"2025-03-28","objectID":"/zh-cn/advanced-modelling/:3:3","tags":["åŒ–å­¦ä¿¡æ¯å­¦","è®¡ç®—è¯ç‰©åŒ–å­¦","Pharameutical Modelling"],"title":"ä¹Œæ™®è¨æ‹‰å¤§å­¦ Advanced Molecular Modelling Applied to Drug Discovery(3FK181) è¯¾ç¨‹å¤ä¹ ç¬”è®°","uri":"/zh-cn/advanced-modelling/"},{"categories":["åŸºç¡€çŸ¥è¯†","è¯¾ç¨‹"],"content":"IV. For Charged Molecules UC = qâ‚qâ‚‚/4Ï€Îµâ‚€râ‚j Very expensive to calculation ","date":"2025-03-28","objectID":"/zh-cn/advanced-modelling/:3:4","tags":["åŒ–å­¦ä¿¡æ¯å­¦","è®¡ç®—è¯ç‰©åŒ–å­¦","Pharameutical Modelling"],"title":"ä¹Œæ™®è¨æ‹‰å¤§å­¦ Advanced Molecular Modelling Applied to Drug Discovery(3FK181) è¯¾ç¨‹å¤ä¹ ç¬”è®°","uri":"/zh-cn/advanced-modelling/"},{"categories":["åŸºç¡€çŸ¥è¯†","è¯¾ç¨‹"],"content":"V. Bond Potential (Hookeâ€™s Law) Accurate Morse potential typically replaced with simpler harmonic function (ç®€è°å‡½æ•°) Bond: U = kâ‚/2(r-râ‚€)Â² Angle: U = kâ‚‚/2(Î¸-Î¸â‚€)Â² ","date":"2025-03-28","objectID":"/zh-cn/advanced-modelling/:3:5","tags":["åŒ–å­¦ä¿¡æ¯å­¦","è®¡ç®—è¯ç‰©åŒ–å­¦","Pharameutical Modelling"],"title":"ä¹Œæ™®è¨æ‹‰å¤§å­¦ Advanced Molecular Modelling Applied to Drug Discovery(3FK181) è¯¾ç¨‹å¤ä¹ ç¬”è®°","uri":"/zh-cn/advanced-modelling/"},{"categories":["åŸºç¡€çŸ¥è¯†","è¯¾ç¨‹"],"content":"VI. Consider Partial Charges Water: partially charged â†’ Water models: TIP3P, SPC ","date":"2025-03-28","objectID":"/zh-cn/advanced-modelling/:3:6","tags":["åŒ–å­¦ä¿¡æ¯å­¦","è®¡ç®—è¯ç‰©åŒ–å­¦","Pharameutical Modelling"],"title":"ä¹Œæ™®è¨æ‹‰å¤§å­¦ Advanced Molecular Modelling Applied to Drug Discovery(3FK181) è¯¾ç¨‹å¤ä¹ ç¬”è®°","uri":"/zh-cn/advanced-modelling/"},{"categories":["åŸºç¡€çŸ¥è¯†","è¯¾ç¨‹"],"content":"VII. Consider Torsional Potential (æ‰­è½¬åŠ¿èƒ½) U(Ï†) = Î£(k_n/2)[1+cos(nÏ†-Ï†â‚€)] n = number of minima è‹¥æœ‰3ä¸ª minimal, n=3, Ï†â‚€=0 U(Ï†) = kâ‚/2[1+cos(Ï†)] + kâ‚‚/2[1+cos(2Ï†)] + kâ‚ƒ/2[1+cos(3Ï†)] Problems: Complex shape Relatively weak Torsion may lead to large changes to the whole system Addition: Improper dihedrals â†’ keep 4 atoms in a plane Total energy function: U = 4Îµ[(Ïƒ/r)Â¹Â² - (Ïƒ/r)â¶] + qâ‚qâ‚‚/4Ï€Îµâ‚€râ‚j + kâ‚/2(r-râ‚€)Â² + kâ‚‚/2(Î¸-Î¸â‚€)Â² + Î£(k_n/2)[1+cos(nÏ†-Ï†â‚€)] + kâ‚ƒ/2(Î¾-Î¾â‚€)Â² ","date":"2025-03-28","objectID":"/zh-cn/advanced-modelling/:3:7","tags":["åŒ–å­¦ä¿¡æ¯å­¦","è®¡ç®—è¯ç‰©åŒ–å­¦","Pharameutical Modelling"],"title":"ä¹Œæ™®è¨æ‹‰å¤§å­¦ Advanced Molecular Modelling Applied to Drug Discovery(3FK181) è¯¾ç¨‹å¤ä¹ ç¬”è®°","uri":"/zh-cn/advanced-modelling/"},{"categories":["åŸºç¡€çŸ¥è¯†","è¯¾ç¨‹"],"content":"Summary of Force Field Itâ€™s empirical! (ç»éªŒä¸Š) There is no correct way to derive a force field; experimental data improves it Fits reality, not theory - aim is to reproduce experimental results, not calculate it Predict, not explain Consider computational time; the best model isnâ€™t always chosen ","date":"2025-03-28","objectID":"/zh-cn/advanced-modelling/:3:8","tags":["åŒ–å­¦ä¿¡æ¯å­¦","è®¡ç®—è¯ç‰©åŒ–å­¦","Pharameutical Modelling"],"title":"ä¹Œæ™®è¨æ‹‰å¤§å­¦ Advanced Molecular Modelling Applied to Drug Discovery(3FK181) è¯¾ç¨‹å¤ä¹ ç¬”è®°","uri":"/zh-cn/advanced-modelling/"},{"categories":["åŸºç¡€çŸ¥è¯†","è¯¾ç¨‹"],"content":"Biomolecular Simulation VIII. AMBER Assisted model building with energy refinements Helps with: Bond stretching, angle bending, dihedral torsional angles Interaction with other models Structure ","date":"2025-03-28","objectID":"/zh-cn/advanced-modelling/:3:9","tags":["åŒ–å­¦ä¿¡æ¯å­¦","è®¡ç®—è¯ç‰©åŒ–å­¦","Pharameutical Modelling"],"title":"ä¹Œæ™®è¨æ‹‰å¤§å­¦ Advanced Molecular Modelling Applied to Drug Discovery(3FK181) è¯¾ç¨‹å¤ä¹ ç¬”è®°","uri":"/zh-cn/advanced-modelling/"},{"categories":["åŸºç¡€çŸ¥è¯†","è¯¾ç¨‹"],"content":"Force Field Summary Force field is simplified and empirical (ç»éªŒä¸Š) Form and parameters differ in different models Usefulness depends on the question being asked Major problem: Bonds cannot be broken Transferability of parameters is unclear The ability to transfer parameters from one molecule to another (å‚æ•°çš„è½¬ç§»æ€§) Assumption: similar molecules have the same parameters Even if they have similar structure Consider environment, temperature, and other molecules Polarization is not included General methods of generating parameters are still under development ","date":"2025-03-28","objectID":"/zh-cn/advanced-modelling/:3:10","tags":["åŒ–å­¦ä¿¡æ¯å­¦","è®¡ç®—è¯ç‰©åŒ–å­¦","Pharameutical Modelling"],"title":"ä¹Œæ™®è¨æ‹‰å¤§å­¦ Advanced Molecular Modelling Applied to Drug Discovery(3FK181) è¯¾ç¨‹å¤ä¹ ç¬”è®°","uri":"/zh-cn/advanced-modelling/"},{"categories":["åŸºç¡€çŸ¥è¯†","è¯¾ç¨‹"],"content":"Modeling Complex Biomolecules Formula combines bond energies, angle energies, torsional terms, improper terms, electrostatic and VDW terms We have force field parameters for amino acids What about larger biomolecules? ","date":"2025-03-28","objectID":"/zh-cn/advanced-modelling/:3:11","tags":["åŒ–å­¦ä¿¡æ¯å­¦","è®¡ç®—è¯ç‰©åŒ–å­¦","Pharameutical Modelling"],"title":"ä¹Œæ™®è¨æ‹‰å¤§å­¦ Advanced Molecular Modelling Applied to Drug Discovery(3FK181) è¯¾ç¨‹å¤ä¹ ç¬”è®°","uri":"/zh-cn/advanced-modelling/"},{"categories":["åŸºç¡€çŸ¥è¯†","è¯¾ç¨‹"],"content":"Free Energy vs Potential Energy The minimum potential energy state need not be the most popular state; free energy is G = H - TS â†’ Entropy Enthalpy considerations Take average of a huge number of particles Experiment observation based on a single configuration ","date":"2025-03-28","objectID":"/zh-cn/advanced-modelling/:3:12","tags":["åŒ–å­¦ä¿¡æ¯å­¦","è®¡ç®—è¯ç‰©åŒ–å­¦","Pharameutical Modelling"],"title":"ä¹Œæ™®è¨æ‹‰å¤§å­¦ Advanced Molecular Modelling Applied to Drug Discovery(3FK181) è¯¾ç¨‹å¤ä¹ ç¬”è®°","uri":"/zh-cn/advanced-modelling/"},{"categories":["åŸºç¡€çŸ¥è¯†","è¯¾ç¨‹"],"content":"Time Average \u003c A \u003e = (1/Ï„)âˆ«â‚€áµ— A(r^N(t), p^N(t))dt r: position; p: momenta; of all particles N (ç²’å­ä½ç½®å’ŒåŠ¨é‡), Ï„â†’âˆ, å¹³å‡å³ä¸ºå®é™… ","date":"2025-03-28","objectID":"/zh-cn/advanced-modelling/:3:13","tags":["åŒ–å­¦ä¿¡æ¯å­¦","è®¡ç®—è¯ç‰©åŒ–å­¦","Pharameutical Modelling"],"title":"ä¹Œæ™®è¨æ‹‰å¤§å­¦ Advanced Molecular Modelling Applied to Drug Discovery(3FK181) è¯¾ç¨‹å¤ä¹ ç¬”è®°","uri":"/zh-cn/advanced-modelling/"},{"categories":["åŸºç¡€çŸ¥è¯†","è¯¾ç¨‹"],"content":"Statistical Thermodynamics Know the probability of every state n_i = NÂ·(e^(-Î²E_i)/Î£â±¼e^(-Î²E_j)) n_i: number in a state åˆ©ç”¨\"æ¦‚ç‡\" Ergodic hypothesis (éå†å‡è®¾): Time average = Ensemble average ","date":"2025-03-28","objectID":"/zh-cn/advanced-modelling/:3:14","tags":["åŒ–å­¦ä¿¡æ¯å­¦","è®¡ç®—è¯ç‰©åŒ–å­¦","Pharameutical Modelling"],"title":"ä¹Œæ™®è¨æ‹‰å¤§å­¦ Advanced Molecular Modelling Applied to Drug Discovery(3FK181) è¯¾ç¨‹å¤ä¹ ç¬”è®°","uri":"/zh-cn/advanced-modelling/"},{"categories":["åŸºç¡€çŸ¥è¯†","è¯¾ç¨‹"],"content":"Sampling an Energy Landscape MD Simulation uses: Newtonâ€™s laws Time dependence Time average Dynamical events ","date":"2025-03-28","objectID":"/zh-cn/advanced-modelling/:3:15","tags":["åŒ–å­¦ä¿¡æ¯å­¦","è®¡ç®—è¯ç‰©åŒ–å­¦","Pharameutical Modelling"],"title":"ä¹Œæ™®è¨æ‹‰å¤§å­¦ Advanced Molecular Modelling Applied to Drug Discovery(3FK181) è¯¾ç¨‹å¤ä¹ ç¬”è®°","uri":"/zh-cn/advanced-modelling/"},{"categories":["åŸºç¡€çŸ¥è¯†","è¯¾ç¨‹"],"content":"Molecular Dynamics Simulation (åˆ†å­åŠ¨åŠ›å­¦ Force Field) Try to calculate the path of individual particles Errors occur but final results are acceptable Calculate motion as a function of time ","date":"2025-03-28","objectID":"/zh-cn/advanced-modelling/:3:16","tags":["åŒ–å­¦ä¿¡æ¯å­¦","è®¡ç®—è¯ç‰©åŒ–å­¦","Pharameutical Modelling"],"title":"ä¹Œæ™®è¨æ‹‰å¤§å­¦ Advanced Molecular Modelling Applied to Drug Discovery(3FK181) è¯¾ç¨‹å¤ä¹ ç¬”è®°","uri":"/zh-cn/advanced-modelling/"},{"categories":["åŸºç¡€çŸ¥è¯†","è¯¾ç¨‹"],"content":"MD Process Start with a set of coordinates Calculate potential and force (ç”¨æ—¶æ—¶æ‰€è¿­) Calculate acceleration: a_i = F_i/m_i Calculate velocity and position: v + dt ","date":"2025-03-28","objectID":"/zh-cn/advanced-modelling/:3:17","tags":["åŒ–å­¦ä¿¡æ¯å­¦","è®¡ç®—è¯ç‰©åŒ–å­¦","Pharameutical Modelling"],"title":"ä¹Œæ™®è¨æ‹‰å¤§å­¦ Advanced Molecular Modelling Applied to Drug Discovery(3FK181) è¯¾ç¨‹å¤ä¹ ç¬”è®°","uri":"/zh-cn/advanced-modelling/"},{"categories":["åŸºç¡€çŸ¥è¯†","è¯¾ç¨‹"],"content":"Leap-Frog Algorithm Calculate new coordinates for atoms (è¿­ä»£ç®—æ³•) r_i(t+dt) = r_i(t) + dtÂ·v_i(t+dt/2) ","date":"2025-03-28","objectID":"/zh-cn/advanced-modelling/:3:18","tags":["åŒ–å­¦ä¿¡æ¯å­¦","è®¡ç®—è¯ç‰©åŒ–å­¦","Pharameutical Modelling"],"title":"ä¹Œæ™®è¨æ‹‰å¤§å­¦ Advanced Molecular Modelling Applied to Drug Discovery(3FK181) è¯¾ç¨‹å¤ä¹ ç¬”è®°","uri":"/zh-cn/advanced-modelling/"},{"categories":["åŸºç¡€çŸ¥è¯†","è¯¾ç¨‹"],"content":"For Trajectory (è½¨è¿¹) Different time series of snapshots In theory, MD simulation is deterministic (ç¡®å®šæ€§çš„) If we know the state, we can predict behavior In practice, errors accumulate Looking over long time provides a good picture ","date":"2025-03-28","objectID":"/zh-cn/advanced-modelling/:3:19","tags":["åŒ–å­¦ä¿¡æ¯å­¦","è®¡ç®—è¯ç‰©åŒ–å­¦","Pharameutical Modelling"],"title":"ä¹Œæ™®è¨æ‹‰å¤§å­¦ Advanced Molecular Modelling Applied to Drug Discovery(3FK181) è¯¾ç¨‹å¤ä¹ ç¬”è®°","uri":"/zh-cn/advanced-modelling/"},{"categories":["åŸºç¡€çŸ¥è¯†","è¯¾ç¨‹"],"content":"How to Choose Time Step Must be small but not too small (need more to reach 1ms simulation) If step is too big â†’ unreasonable positions Determined by the fastest vibration in system Typically choose 1-2 fs ","date":"2025-03-28","objectID":"/zh-cn/advanced-modelling/:3:20","tags":["åŒ–å­¦ä¿¡æ¯å­¦","è®¡ç®—è¯ç‰©åŒ–å­¦","Pharameutical Modelling"],"title":"ä¹Œæ™®è¨æ‹‰å¤§å­¦ Advanced Molecular Modelling Applied to Drug Discovery(3FK181) è¯¾ç¨‹å¤ä¹ ç¬”è®°","uri":"/zh-cn/advanced-modelling/"},{"categories":["åŸºç¡€çŸ¥è¯†","è¯¾ç¨‹"],"content":"Solvation in MD Vacuum: No solvent, problematic Implicit solvent model: Replaced by average behavior of water Analytical, so calculations are fast Disadvantage: Only electrostatics in this expression Other effects like entropy must be added separately SBC (Spherical Boundary Condition): Add water near the place of interest Save time if not considering whole protein Should restrain water inside the spherical boundary Should add right polarization PBC (Periodic Boundary Condition): Create â€œinfiniteâ€ system by creating identical copies Use a periodic cell shape and cut-offs When we define a â€œprimary cellâ€, we copy it When an atom reaches edge, it enters from another side Advantage: Use less atoms to simulate a large system Computationally expensive ","date":"2025-03-28","objectID":"/zh-cn/advanced-modelling/:3:21","tags":["åŒ–å­¦ä¿¡æ¯å­¦","è®¡ç®—è¯ç‰©åŒ–å­¦","Pharameutical Modelling"],"title":"ä¹Œæ™®è¨æ‹‰å¤§å­¦ Advanced Molecular Modelling Applied to Drug Discovery(3FK181) è¯¾ç¨‹å¤ä¹ ç¬”è®°","uri":"/zh-cn/advanced-modelling/"},{"categories":["åŸºç¡€çŸ¥è¯†","è¯¾ç¨‹"],"content":"Common Ensembles NVT (Canonical): Control T (ç­‰å®¹ç­‰æ¸©) NPT (Isobaric-Isothermal): Control T \u0026 P (ç­‰å‹ç­‰æ¸©) Temperature â†’ Kinetic energy â†’ Velocity ","date":"2025-03-28","objectID":"/zh-cn/advanced-modelling/:3:22","tags":["åŒ–å­¦ä¿¡æ¯å­¦","è®¡ç®—è¯ç‰©åŒ–å­¦","Pharameutical Modelling"],"title":"ä¹Œæ™®è¨æ‹‰å¤§å­¦ Advanced Molecular Modelling Applied to Drug Discovery(3FK181) è¯¾ç¨‹å¤ä¹ ç¬”è®°","uri":"/zh-cn/advanced-modelling/"},{"categories":["åŸºç¡€çŸ¥è¯†","è¯¾ç¨‹"],"content":"Limitations of MD Parameters are not perfect Amino acid solvent free energy: ~1kJ/mol Impossible to calculate binding energy more accurately Phase space not fully sampled (ç›¸ç©ºé—´æœªå®Œå…¨é‡‡æ ·) Limited polarization effects (æåŒ–é™åˆ¶): Water reorientation Partial charge is fixed (The orientation change) ","date":"2025-03-28","objectID":"/zh-cn/advanced-modelling/:3:23","tags":["åŒ–å­¦ä¿¡æ¯å­¦","è®¡ç®—è¯ç‰©åŒ–å­¦","Pharameutical Modelling"],"title":"ä¹Œæ™®è¨æ‹‰å¤§å­¦ Advanced Molecular Modelling Applied to Drug Discovery(3FK181) è¯¾ç¨‹å¤ä¹ ç¬”è®°","uri":"/zh-cn/advanced-modelling/"},{"categories":["åŸºç¡€çŸ¥è¯†","è¯¾ç¨‹"],"content":"MD Workflow Get structure â†’ Fix structure â†’ Prepare topology â†’ Add water â†’ Energy min. â†’ Equilibration phase â†’ Run â†’ Analysis ","date":"2025-03-28","objectID":"/zh-cn/advanced-modelling/:3:24","tags":["åŒ–å­¦ä¿¡æ¯å­¦","è®¡ç®—è¯ç‰©åŒ–å­¦","Pharameutical Modelling"],"title":"ä¹Œæ™®è¨æ‹‰å¤§å­¦ Advanced Molecular Modelling Applied to Drug Discovery(3FK181) è¯¾ç¨‹å¤ä¹ ç¬”è®°","uri":"/zh-cn/advanced-modelling/"},{"categories":["åŸºç¡€çŸ¥è¯†","è¯¾ç¨‹"],"content":"MD Outcomes Doesnâ€™t mean itâ€™s â€œrealâ€ Everything is about statistics Error? A signal event is not ","date":"2025-03-28","objectID":"/zh-cn/advanced-modelling/:3:25","tags":["åŒ–å­¦ä¿¡æ¯å­¦","è®¡ç®—è¯ç‰©åŒ–å­¦","Pharameutical Modelling"],"title":"ä¹Œæ™®è¨æ‹‰å¤§å­¦ Advanced Molecular Modelling Applied to Drug Discovery(3FK181) è¯¾ç¨‹å¤ä¹ ç¬”è®°","uri":"/zh-cn/advanced-modelling/"},{"categories":["åŸºç¡€çŸ¥è¯†","è¯¾ç¨‹"],"content":"Chapter 3: Free Energy ","date":"2025-03-28","objectID":"/zh-cn/advanced-modelling/:4:0","tags":["åŒ–å­¦ä¿¡æ¯å­¦","è®¡ç®—è¯ç‰©åŒ–å­¦","Pharameutical Modelling"],"title":"ä¹Œæ™®è¨æ‹‰å¤§å­¦ Advanced Molecular Modelling Applied to Drug Discovery(3FK181) è¯¾ç¨‹å¤ä¹ ç¬”è®°","uri":"/zh-cn/advanced-modelling/"},{"categories":["åŸºç¡€çŸ¥è¯†","è¯¾ç¨‹"],"content":"I. Free Energy Basics Î”G\u003c0: Reaction is spontaneous (è‡ªå‘çš„) ","date":"2025-03-28","objectID":"/zh-cn/advanced-modelling/:4:1","tags":["åŒ–å­¦ä¿¡æ¯å­¦","è®¡ç®—è¯ç‰©åŒ–å­¦","Pharameutical Modelling"],"title":"ä¹Œæ™®è¨æ‹‰å¤§å­¦ Advanced Molecular Modelling Applied to Drug Discovery(3FK181) è¯¾ç¨‹å¤ä¹ ç¬”è®°","uri":"/zh-cn/advanced-modelling/"},{"categories":["åŸºç¡€çŸ¥è¯†","è¯¾ç¨‹"],"content":"II. Absolute Free Energy Calculation Hard/impossible to calculate directly Need to sample all parts of phase space Typical simulations only sample low-energy regions ","date":"2025-03-28","objectID":"/zh-cn/advanced-modelling/:4:2","tags":["åŒ–å­¦ä¿¡æ¯å­¦","è®¡ç®—è¯ç‰©åŒ–å­¦","Pharameutical Modelling"],"title":"ä¹Œæ™®è¨æ‹‰å¤§å­¦ Advanced Molecular Modelling Applied to Drug Discovery(3FK181) è¯¾ç¨‹å¤ä¹ ç¬”è®°","uri":"/zh-cn/advanced-modelling/"},{"categories":["åŸºç¡€çŸ¥è¯†","è¯¾ç¨‹"],"content":"III. Thermodynamic Perturbation (å¹²æ‰°) F_Aâ†’B = F_B - F_A = -k_BÂ·TÂ·ln(Q_B/Q_A) Zwanzigâ€™s Formula: F_Aâ†’B = -kTÂ·ln\u003ce^(-Î”H/Î²)\u003e_A How to use Zwanzigâ€™s Formula: Calculate Î”G to go to B Potential Energy of A and B (åŠ¿èƒ½) Assumption: A-B gap is not big ","date":"2025-03-28","objectID":"/zh-cn/advanced-modelling/:4:3","tags":["åŒ–å­¦ä¿¡æ¯å­¦","è®¡ç®—è¯ç‰©åŒ–å­¦","Pharameutical Modelling"],"title":"ä¹Œæ™®è¨æ‹‰å¤§å­¦ Advanced Molecular Modelling Applied to Drug Discovery(3FK181) è¯¾ç¨‹å¤ä¹ ç¬”è®°","uri":"/zh-cn/advanced-modelling/"},{"categories":["åŸºç¡€çŸ¥è¯†","è¯¾ç¨‹"],"content":"IV. Thermodynamic Cycle Path not necessary to be meaningful A â†’ B â†’ C â†’ D: Î”G_AB + Î”G_DA - Î”G_CB - Î”G_DC = 0 ","date":"2025-03-28","objectID":"/zh-cn/advanced-modelling/:4:4","tags":["åŒ–å­¦ä¿¡æ¯å­¦","è®¡ç®—è¯ç‰©åŒ–å­¦","Pharameutical Modelling"],"title":"ä¹Œæ™®è¨æ‹‰å¤§å­¦ Advanced Molecular Modelling Applied to Drug Discovery(3FK181) è¯¾ç¨‹å¤ä¹ ç¬”è®°","uri":"/zh-cn/advanced-modelling/"},{"categories":["åŸºç¡€çŸ¥è¯†","è¯¾ç¨‹"],"content":"V. Fixing the Overlap Problem H(Î») = (1-Î»)H_A + Î»H_B Î» is interpolation parameter (åŠ å…¥Î»ä¸ºä¸­é—´æ€) F_B - F_A = (F_Î»=0.5 - F_Î»=0) + (F_Î»=1 - F_Î»=0.5) ","date":"2025-03-28","objectID":"/zh-cn/advanced-modelling/:4:5","tags":["åŒ–å­¦ä¿¡æ¯å­¦","è®¡ç®—è¯ç‰©åŒ–å­¦","Pharameutical Modelling"],"title":"ä¹Œæ™®è¨æ‹‰å¤§å­¦ Advanced Molecular Modelling Applied to Drug Discovery(3FK181) è¯¾ç¨‹å¤ä¹ ç¬”è®°","uri":"/zh-cn/advanced-modelling/"},{"categories":["åŸºç¡€çŸ¥è¯†","è¯¾ç¨‹"],"content":"VI. Solvation Process Î”G_Sol = Î”G_VdW + Î”G_Charge + Î”G_Cav VdW: van der Waals interaction between L-J atoms Charge: Electrostatics Cav: Cost for creating cavity in water (surface/entropy) ","date":"2025-03-28","objectID":"/zh-cn/advanced-modelling/:4:6","tags":["åŒ–å­¦ä¿¡æ¯å­¦","è®¡ç®—è¯ç‰©åŒ–å­¦","Pharameutical Modelling"],"title":"ä¹Œæ™®è¨æ‹‰å¤§å­¦ Advanced Molecular Modelling Applied to Drug Discovery(3FK181) è¯¾ç¨‹å¤ä¹ ç¬”è®°","uri":"/zh-cn/advanced-modelling/"},{"categories":["åŸºç¡€çŸ¥è¯†","è¯¾ç¨‹"],"content":"VII. Thermodynamic Integration (ç§¯åˆ†) Î”F = âˆ«â‚€Â¹\u003cH_B - H_A\u003e_Î» dÎ» ","date":"2025-03-28","objectID":"/zh-cn/advanced-modelling/:4:7","tags":["åŒ–å­¦ä¿¡æ¯å­¦","è®¡ç®—è¯ç‰©åŒ–å­¦","Pharameutical Modelling"],"title":"ä¹Œæ™®è¨æ‹‰å¤§å­¦ Advanced Molecular Modelling Applied to Drug Discovery(3FK181) è¯¾ç¨‹å¤ä¹ ç¬”è®°","uri":"/zh-cn/advanced-modelling/"},{"categories":["åŸºç¡€çŸ¥è¯†","è¯¾ç¨‹"],"content":"VIII. Inhibitor Design If we know an inhibitor, we want a similar one (I = protein) ç”¨äºåˆ›æ–°è®¾è®¡ç®—æ³• I+E â†’ I'+E' â†‘ â†‘ I I' F_Iâ†’Iâ€™_bind - F_Iâ†’Iâ€™_bind = F_Iâ†’Iâ€™_bound - F_Iâ†’Iâ€™_Free ","date":"2025-03-28","objectID":"/zh-cn/advanced-modelling/:4:8","tags":["åŒ–å­¦ä¿¡æ¯å­¦","è®¡ç®—è¯ç‰©åŒ–å­¦","Pharameutical Modelling"],"title":"ä¹Œæ™®è¨æ‹‰å¤§å­¦ Advanced Molecular Modelling Applied to Drug Discovery(3FK181) è¯¾ç¨‹å¤ä¹ ç¬”è®°","uri":"/zh-cn/advanced-modelling/"},{"categories":["åŸºç¡€çŸ¥è¯†","è¯¾ç¨‹"],"content":"Chapter 4: Quantum Chemistry ","date":"2025-03-28","objectID":"/zh-cn/advanced-modelling/:5:0","tags":["åŒ–å­¦ä¿¡æ¯å­¦","è®¡ç®—è¯ç‰©åŒ–å­¦","Pharameutical Modelling"],"title":"ä¹Œæ™®è¨æ‹‰å¤§å­¦ Advanced Molecular Modelling Applied to Drug Discovery(3FK181) è¯¾ç¨‹å¤ä¹ ç¬”è®°","uri":"/zh-cn/advanced-modelling/"},{"categories":["åŸºç¡€çŸ¥è¯†","è¯¾ç¨‹"],"content":"I. Why Quantum Chemistry? No parameters required Explicit treatment of electrons In principle, everything can be modeled: Polarization, reactions, spectroscopy ","date":"2025-03-28","objectID":"/zh-cn/advanced-modelling/:5:1","tags":["åŒ–å­¦ä¿¡æ¯å­¦","è®¡ç®—è¯ç‰©åŒ–å­¦","Pharameutical Modelling"],"title":"ä¹Œæ™®è¨æ‹‰å¤§å­¦ Advanced Molecular Modelling Applied to Drug Discovery(3FK181) è¯¾ç¨‹å¤ä¹ ç¬”è®°","uri":"/zh-cn/advanced-modelling/"},{"categories":["åŸºç¡€çŸ¥è¯†","è¯¾ç¨‹"],"content":"II. Postulates of Quantum Mechanics State of quantum mechanical system completely specified by wavefunction Î¨(r,t) r: vector in 3D space (ä¸‰ç»´ç©ºé—´çš„ä¸€ä¸ªæ–¹å‘é‡) t: time Born Interpretation: Square of wave function â†’ probability of finding the system at given values of the variable p(xâ‚,xâ‚‚) = âˆ«|Î¨(x)|Â²dx æ¦‚ç‡ For every observable in classical mechanics, there is an operator in QC (æŠŠä¼ ç»ŸåŠ›å­¦é‡ç”¨é‡å­ç®—ç¬¦è¡¨è¾¾äº’è”ç³»èµ·æ¥) In any measurement of the observable associated with operator Ã‚, the only values ever observed are the eigenvalues a Ã‚Î¨ = aÎ¨ Ã‚ä¸ºç‰©ç†é‡, Ã‚å¯¹åº”äºÏˆ, åˆ™Ã‚çš„aä½œç”¨äºÏˆ, åˆ™Ã‚Ïˆa It can be averaged: \u003c A \u003e = âˆ«Î¨Ã‚Î¨dÏ„/âˆ«Î¨Î¨dÏ„ SchrÃ¶dinger Equation: Time-dependent: Ã‚Î¨(r,t) = iâ„âˆ‚Î¨(r,t)/âˆ‚t For time-independent systems: (Ã‚-E)Î¨(r) â†’ the systemâ€™s eigenvalues ","date":"2025-03-28","objectID":"/zh-cn/advanced-modelling/:5:2","tags":["åŒ–å­¦ä¿¡æ¯å­¦","è®¡ç®—è¯ç‰©åŒ–å­¦","Pharameutical Modelling"],"title":"ä¹Œæ™®è¨æ‹‰å¤§å­¦ Advanced Molecular Modelling Applied to Drug Discovery(3FK181) è¯¾ç¨‹å¤ä¹ ç¬”è®°","uri":"/zh-cn/advanced-modelling/"},{"categories":["åŸºç¡€çŸ¥è¯†","è¯¾ç¨‹"],"content":"Born-Oppenheimer Approximation Assumes m_nuclei Â» m_electron Electrons move faster Electrons adjust immediately to nuclear movement The operator of electrons doesnâ€™t include the kinetic of nuclei (åŠ¨æ ¸è¿‘ä¼¼) H_e = T_e + V_ee + V_en + V_nn Separation of Variables n electrons moving independently: Î¨ = Î Î¦áµ¢ E = Î£Eáµ¢ Pauli Principle and Slater Determinant Pauli exclusion principle: Two or more electrons cannot occupy the same quantum state (ä¸€ä¸ªç”µå­ä¸å¯å¤„äºåŒä¸€é‡å­æ€) Slater determinant: Follow the Pauli principle When two electrons exchange location, wavefunction changes sign For n=2 electrons: Î¨ = (1/âˆš2)|Î¦â‚(1) Î¦â‚‚(1)| / |Î¦â‚(2) Î¦â‚‚(2)| Consequences of Slater determinant: Follow electron Pauli principle Consider electron correlation Consider charge exchange ","date":"2025-03-28","objectID":"/zh-cn/advanced-modelling/:5:3","tags":["åŒ–å­¦ä¿¡æ¯å­¦","è®¡ç®—è¯ç‰©åŒ–å­¦","Pharameutical Modelling"],"title":"ä¹Œæ™®è¨æ‹‰å¤§å­¦ Advanced Molecular Modelling Applied to Drug Discovery(3FK181) è¯¾ç¨‹å¤ä¹ ç¬”è®°","uri":"/zh-cn/advanced-modelling/"},{"categories":["åŸºç¡€çŸ¥è¯†","è¯¾ç¨‹"],"content":"Disadvantages Not always accurate Cannot explain correlation energy Computationally difficult ","date":"2025-03-28","objectID":"/zh-cn/advanced-modelling/:5:4","tags":["åŒ–å­¦ä¿¡æ¯å­¦","è®¡ç®—è¯ç‰©åŒ–å­¦","Pharameutical Modelling"],"title":"ä¹Œæ™®è¨æ‹‰å¤§å­¦ Advanced Molecular Modelling Applied to Drug Discovery(3FK181) è¯¾ç¨‹å¤ä¹ ç¬”è®°","uri":"/zh-cn/advanced-modelling/"},{"categories":["åŸºç¡€çŸ¥è¯†","è¯¾ç¨‹"],"content":"III. Hartree-Fock / Self-Consistent Field Slater determinant provides mathematical framework â†’ Hartree-Fock Hartree-Fock calculates the energy of a system (èƒ½é‡) More accurate than simpler methods (æ›´ä¸ºå‡†ç¡®) Hartree-Fock uses basis sets to construct wavefunctions, then adjusts to reality To choose basis sets: Atomic nuclei as centers Mix and match these functions Base: Solution of SchrÃ¶dinger equation of H Radial part is Slater-type orbital (STO) - an exponential function Use Gaussian functions (GTOs) to approximate How many basis sets? One independent minimal set For reasonable results: at least 2 or 3 Add flexibility: add polarization For anions: diffuse functions Split Valence Basis Sets (ä»·å±‚åˆ†è£‚): Valence electrons are more important Use more functions on valence electrons 6-31G(d,p) notation: 6: inner shell electrons represented by 6 Gaussian-type orbitals 3,1: valence shell represented by 3 GTOs for first part, 1 GTO for second d,p: polarization functions (d for heavy atoms, p for hydrogen) Limits of Hartree-Fock: Adding more basis sets is always better In H-F theory, electron-electron interactions treated with mean-field approach (å¹³å‡åœº) In reality, electron movement is correlated Missing: Electron correlation energy (èƒ½é‡) ç›¸å…³æ€§ Post-Hartree-Fock: Correlation effects approximated by including additional determinants CI, MCSCF, MPn methods available ","date":"2025-03-28","objectID":"/zh-cn/advanced-modelling/:5:5","tags":["åŒ–å­¦ä¿¡æ¯å­¦","è®¡ç®—è¯ç‰©åŒ–å­¦","Pharameutical Modelling"],"title":"ä¹Œæ™®è¨æ‹‰å¤§å­¦ Advanced Molecular Modelling Applied to Drug Discovery(3FK181) è¯¾ç¨‹å¤ä¹ ç¬”è®°","uri":"/zh-cn/advanced-modelling/"},{"categories":["åŸºç¡€çŸ¥è¯†","è¯¾ç¨‹"],"content":"IV. Density Functional Theory Energy is a function of electron density: E = F[Ï(r)] where Ï is density, F is a functional Donâ€™t need to solve SchrÃ¶dinger function Only 3N variables needed Hohenberg-Kohn theorem states the function â€œEXISTSâ€ but doesnâ€™t specify what it is We know it includes these parts: E[Ï] = T[Ï] + E_ne[Ï] + E_ee[Ï] T[Ï]: Kinetic energy of electrons E_ne[Ï]: Attraction between nuclei and electrons E_ee[Ï]: Repulsion between electrons E[Ï] = T[Ï] + E_ne[Ï] + J[Ï] + K[Ï] J[Ï]: Coulomb interaction (åº“ä»‘é¡¹) K[Ï]: Exchange term to fit Pauli exclusion principle (äº¤æ¢é¡¹) Kohn-Sham Approach: According to Heisenberg uncertainty principle, we cannot test momentum and location at the same time (æµ‹ä¸å‡†åŸç†ä¸ç¡®å®šæ€§åŸç†) Pä¸ºè¿åŠ¨é‡ï¼Œå¯¹åº”ä½ç½®ï¼Œæ•™æˆåŠ¨èƒ½ Need to know velocity â†’ æ–¹ç¨‹å¼ Hartree-Fock can calculate kinetic energy For Kohn-Sham approach in DFT, add â€œfakeâ€ electrons to get approximate kinetic values DFT in Practice: E[Ï] = T_s[Ï] + E_ne[Ï] + J[Ï] + E_xc[Ï] T_s[Ï]: Kinetic energy from Kohn-Sham orbitals E_xc[Ï]: Other quantum mechanical effects (correlation) Kohn-Sham simplified the function to T_s[Ï] + E_xc[Ï] E_xc[Ï] is hard to calculate Common functionals: B3LYP, 6-31G Balance quality and computational cost Dispersion in DFT: Though dispersion is weak, it increases quickly in larger systems Short distance: electron correlation included in functionals Long distance not included Most functionals fail to represent dispersion at all distances Modern functionals (Minnesota family) take this into account DFT in Drug Design: Parameter generation for small molecules Semi-Empirical Method (åŠç»éªŒæ–¹æ³•): These methods require too much computational time Strategies to reduce computation: Reduce number of functions Reduce number of integrals (ç§¯åˆ†) Approximations made to Hartree-Fock: Core electrons ignored; only consider valence electrons with effective charge Z_eff Only minimal basis set employed Integrals involving more than two centers neglected Remaining integrals are parameterized Neglect Diatomic Differential Overlap approximation: Examples: PM3, PM6, PM7 ","date":"2025-03-28","objectID":"/zh-cn/advanced-modelling/:5:6","tags":["åŒ–å­¦ä¿¡æ¯å­¦","è®¡ç®—è¯ç‰©åŒ–å­¦","Pharameutical Modelling"],"title":"ä¹Œæ™®è¨æ‹‰å¤§å­¦ Advanced Molecular Modelling Applied to Drug Discovery(3FK181) è¯¾ç¨‹å¤ä¹ ç¬”è®°","uri":"/zh-cn/advanced-modelling/"},{"categories":["åŸºç¡€çŸ¥è¯†","è¯¾ç¨‹"],"content":"V. Applying QC (Quantum Chemistry) Energy Landscape: QC bonds are a consequence of PES, not input parameters Different molecules can be part of the same PES Transition State Theory: Reaction coordinate: lowest pathway from reactant to product Transit state: max energy of reaction coordinate This state/enzyme must be stable Geometry Optimization: For force fields, minimum energy when gradient becomes close to zero (energy minimum) For QC: Several maxima/minima Optimization to saddle points Curvature calculation needed (æ›²ç‡) Hessian Matrix: Contains all second derivatives For energy minimum, all eigenvalues are positive For transition state, one eigenvalue is negative For second-order saddle point, two eigenvalues are negative / opposite sign Hessian Matrix and Spectroscopy: Hessian matrix used to understand vibration If molecular vibration is harmonic, we can solve SchrÃ¶dinger equation E_vib = â„(n+Â½)âˆš(k/Î¼), n = energy level Between different energy levels â†’ spectroscopic transition Isotope Effect (åŒä½ç´ ): Start from Eâ°_vib = Â½â„âˆš(k/Î¼) where Î¼ is reduced mass For H and D as example: Eâ°_H \u003e Eâ°_D, so Î”E_H \u003c Î”E_D In drug design: -O-CHâ‚ƒ â†’ -O-CDâ‚ƒ Metabolized slowly, less frequent dosing Enthalpies and Free Energy: QC energy results include: Electrons at 0K Electrons and nuclei strictly separated Absolute energy not useful; compare to others with same electron and nuclei configurations, using same method and basis set Electronic energy â†’ Enthalpies considering thermal energies (translation, rotation, vibration) ","date":"2025-03-28","objectID":"/zh-cn/advanced-modelling/:5:7","tags":["åŒ–å­¦ä¿¡æ¯å­¦","è®¡ç®—è¯ç‰©åŒ–å­¦","Pharameutical Modelling"],"title":"ä¹Œæ™®è¨æ‹‰å¤§å­¦ Advanced Molecular Modelling Applied to Drug Discovery(3FK181) è¯¾ç¨‹å¤ä¹ ç¬”è®°","uri":"/zh-cn/advanced-modelling/"},{"categories":["åŸºç¡€çŸ¥è¯†","è¯¾ç¨‹"],"content":"Chapter 5: Cheminformatics ","date":"2025-03-28","objectID":"/zh-cn/advanced-modelling/:6:0","tags":["åŒ–å­¦ä¿¡æ¯å­¦","è®¡ç®—è¯ç‰©åŒ–å­¦","Pharameutical Modelling"],"title":"ä¹Œæ™®è¨æ‹‰å¤§å­¦ Advanced Molecular Modelling Applied to Drug Discovery(3FK181) è¯¾ç¨‹å¤ä¹ ç¬”è®°","uri":"/zh-cn/advanced-modelling/"},{"categories":["åŸºç¡€çŸ¥è¯†","è¯¾ç¨‹"],"content":"I. Different Databases Database comparison: Database Pros Cons SciFinder/eMolecule Variety from multiple sources Inconsistency: Different sources may have different expressions Verified data, commercially available Cost: Pay for subscription GDB-17 Huge database Too large to search effectively Creative: may include molecules not synthesized yet May not be able to be synthesized Single Vendor (Enamine/ChemDiv) Consistency: Same expression format Limited diversity Quality data Dependence: rely on single vendor for data ","date":"2025-03-28","objectID":"/zh-cn/advanced-modelling/:6:1","tags":["åŒ–å­¦ä¿¡æ¯å­¦","è®¡ç®—è¯ç‰©åŒ–å­¦","Pharameutical Modelling"],"title":"ä¹Œæ™®è¨æ‹‰å¤§å­¦ Advanced Molecular Modelling Applied to Drug Discovery(3FK181) è¯¾ç¨‹å¤ä¹ ç¬”è®°","uri":"/zh-cn/advanced-modelling/"},{"categories":["åŸºç¡€çŸ¥è¯†","è¯¾ç¨‹"],"content":"II. Cheminfo Selection Pre-clean the Database: Remove wrong structures Remove salt and inorganic compounds Remove duplicated and tautomers Manual inspection, remove obvious unreasonable data General Chemical Prototyping: Compare active compounds if available Exclude toxic structures and structures leading to similar analogues Consider hydrophobic cores, rotatable bonds if target is known Remove reactive functional groups (ensure selectivity) Remove PAINS (Pan-Assay Interference Compounds) to ensure druggability Create analogues to test affinity with docking Diversity: PCA with physical chemical parameters, clustering If high affinity is found, use it as a lead compound considering: Size Flexibility Lipophilicity ","date":"2025-03-28","objectID":"/zh-cn/advanced-modelling/:6:2","tags":["åŒ–å­¦ä¿¡æ¯å­¦","è®¡ç®—è¯ç‰©åŒ–å­¦","Pharameutical Modelling"],"title":"ä¹Œæ™®è¨æ‹‰å¤§å­¦ Advanced Molecular Modelling Applied to Drug Discovery(3FK181) è¯¾ç¨‹å¤ä¹ ç¬”è®°","uri":"/zh-cn/advanced-modelling/"},{"categories":["åŸºç¡€çŸ¥è¯†","è¯¾ç¨‹"],"content":"Chapter 6: Virtual Screening ","date":"2025-03-28","objectID":"/zh-cn/advanced-modelling/:7:0","tags":["åŒ–å­¦ä¿¡æ¯å­¦","è®¡ç®—è¯ç‰©åŒ–å­¦","Pharameutical Modelling"],"title":"ä¹Œæ™®è¨æ‹‰å¤§å­¦ Advanced Molecular Modelling Applied to Drug Discovery(3FK181) è¯¾ç¨‹å¤ä¹ ç¬”è®°","uri":"/zh-cn/advanced-modelling/"},{"categories":["åŸºç¡€çŸ¥è¯†","è¯¾ç¨‹"],"content":"I. Virtual Screen vs. High-throughput Screening Comparison: Aspect HTS (Physical) VS (Virtual) Location Lab Computer Time Days to weeks Hours to days Cost High Low to medium Compounds 10Â³-10â¶ 10â·-10Â¹Â² Data Generate Experimental Theoretical ","date":"2025-03-28","objectID":"/zh-cn/advanced-modelling/:7:1","tags":["åŒ–å­¦ä¿¡æ¯å­¦","è®¡ç®—è¯ç‰©åŒ–å­¦","Pharameutical Modelling"],"title":"ä¹Œæ™®è¨æ‹‰å¤§å­¦ Advanced Molecular Modelling Applied to Drug Discovery(3FK181) è¯¾ç¨‹å¤ä¹ ç¬”è®°","uri":"/zh-cn/advanced-modelling/"},{"categories":["åŸºç¡€çŸ¥è¯†","è¯¾ç¨‹"],"content":"II. Virtual Screen Methods Docking: Glide Pharmacophore search: Phase Shape similarity: ROCS Electrostatic similarity: EON ","date":"2025-03-28","objectID":"/zh-cn/advanced-modelling/:7:2","tags":["åŒ–å­¦ä¿¡æ¯å­¦","è®¡ç®—è¯ç‰©åŒ–å­¦","Pharameutical Modelling"],"title":"ä¹Œæ™®è¨æ‹‰å¤§å­¦ Advanced Molecular Modelling Applied to Drug Discovery(3FK181) è¯¾ç¨‹å¤ä¹ ç¬”è®°","uri":"/zh-cn/advanced-modelling/"},{"categories":["åŸºç¡€çŸ¥è¯†","è¯¾ç¨‹"],"content":"III. Ligand Efficiency LE = Î”G/N_non-H, where Î”G = -RTlnKd Smaller size means higher affinity to dock the target High efficiency means more druggability, more stable Normalized potency of a hit ","date":"2025-03-28","objectID":"/zh-cn/advanced-modelling/:7:3","tags":["åŒ–å­¦ä¿¡æ¯å­¦","è®¡ç®—è¯ç‰©åŒ–å­¦","Pharameutical Modelling"],"title":"ä¹Œæ™®è¨æ‹‰å¤§å­¦ Advanced Molecular Modelling Applied to Drug Discovery(3FK181) è¯¾ç¨‹å¤ä¹ ç¬”è®°","uri":"/zh-cn/advanced-modelling/"},{"categories":["åŸºç¡€çŸ¥è¯†","è¯¾ç¨‹"],"content":"IV. Negative and Positive Design Negative Design: Avoid undesired properties (e.g., toxicity) Positive Design: Attempt to engineer molecules with desired properties Process: Weeding Out (Negative design): Drug likeness In silico ADMET Frequent hitters Reactive groups Narrowing Down (Positive design): Trend vectors Substructural analysis Similarity searching Profile/landscape analysis (size, electrostatics, HBD/HBA) Focusing In: Structural based models Advanced pharmacophore models Informed docking Informed design ","date":"2025-03-28","objectID":"/zh-cn/advanced-modelling/:7:4","tags":["åŒ–å­¦ä¿¡æ¯å­¦","è®¡ç®—è¯ç‰©åŒ–å­¦","Pharameutical Modelling"],"title":"ä¹Œæ™®è¨æ‹‰å¤§å­¦ Advanced Molecular Modelling Applied to Drug Discovery(3FK181) è¯¾ç¨‹å¤ä¹ ç¬”è®°","uri":"/zh-cn/advanced-modelling/"},{"categories":["åŸºç¡€çŸ¥è¯†","è¯¾ç¨‹"],"content":"V. Frequent Hitters and Promiscuous Binders Frequent hitters: Show activity in many assays; unspecific binding, aggregate, auto-fluorescence. May not be bioactive. Promiscuous binders: Subset of frequent hitter. Can interact with many targets. Bioactive! ","date":"2025-03-28","objectID":"/zh-cn/advanced-modelling/:7:5","tags":["åŒ–å­¦ä¿¡æ¯å­¦","è®¡ç®—è¯ç‰©åŒ–å­¦","Pharameutical Modelling"],"title":"ä¹Œæ™®è¨æ‹‰å¤§å­¦ Advanced Molecular Modelling Applied to Drug Discovery(3FK181) è¯¾ç¨‹å¤ä¹ ç¬”è®°","uri":"/zh-cn/advanced-modelling/"},{"categories":["åŸºç¡€çŸ¥è¯†","è¯¾ç¨‹"],"content":"VI. Benchmark Data Sets Decoy: Has similar chemical structure as active compounds but doesnâ€™t have chemical activity. Use as negative controls in VS. DUD: Directory of decoys, BRAD for ligand-base MUV (Maximum Unbiased Validation): Collection of benchmark datasets DUD: OK for docking MUV: If we want minimal bias Bias: May be easy to select similar molecules but not normal ones Process to create own database benchmark: Create a goal/purpose Collect active compounds Collect inactive compounds (ZINC Database â†’ â€œdrug-likeâ€) Ensure diversity with different structures Split data into training and validation sets Test the method ","date":"2025-03-28","objectID":"/zh-cn/advanced-modelling/:7:6","tags":["åŒ–å­¦ä¿¡æ¯å­¦","è®¡ç®—è¯ç‰©åŒ–å­¦","Pharameutical Modelling"],"title":"ä¹Œæ™®è¨æ‹‰å¤§å­¦ Advanced Molecular Modelling Applied to Drug Discovery(3FK181) è¯¾ç¨‹å¤ä¹ ç¬”è®°","uri":"/zh-cn/advanced-modelling/"},{"categories":["åŸºç¡€çŸ¥è¯†","è¯¾ç¨‹"],"content":"VII. Data Fusion Sum rank, rank vote, sum score EF = (tp/(tp+fp))/(A/T) Pareto rank Test EF 1%, EF 10% ","date":"2025-03-28","objectID":"/zh-cn/advanced-modelling/:7:7","tags":["åŒ–å­¦ä¿¡æ¯å­¦","è®¡ç®—è¯ç‰©åŒ–å­¦","Pharameutical Modelling"],"title":"ä¹Œæ™®è¨æ‹‰å¤§å­¦ Advanced Molecular Modelling Applied to Drug Discovery(3FK181) è¯¾ç¨‹å¤ä¹ ç¬”è®°","uri":"/zh-cn/advanced-modelling/"},{"categories":["åŸºç¡€çŸ¥è¯†","è¯¾ç¨‹"],"content":"VIII. Problems with Decoys Random compounds, decoys data should be similar, cannot divide the active compounds Too similar: Hard to divide and may cause bias From DUD: Some inactive may have active to other target ","date":"2025-03-28","objectID":"/zh-cn/advanced-modelling/:7:8","tags":["åŒ–å­¦ä¿¡æ¯å­¦","è®¡ç®—è¯ç‰©åŒ–å­¦","Pharameutical Modelling"],"title":"ä¹Œæ™®è¨æ‹‰å¤§å­¦ Advanced Molecular Modelling Applied to Drug Discovery(3FK181) è¯¾ç¨‹å¤ä¹ ç¬”è®°","uri":"/zh-cn/advanced-modelling/"},{"categories":["åŸºç¡€çŸ¥è¯†","è¯¾ç¨‹"],"content":"MD \u0026 QC Summary ","date":"2025-03-28","objectID":"/zh-cn/advanced-modelling/:8:0","tags":["åŒ–å­¦ä¿¡æ¯å­¦","è®¡ç®—è¯ç‰©åŒ–å­¦","Pharameutical Modelling"],"title":"ä¹Œæ™®è¨æ‹‰å¤§å­¦ Advanced Molecular Modelling Applied to Drug Discovery(3FK181) è¯¾ç¨‹å¤ä¹ ç¬”è®°","uri":"/zh-cn/advanced-modelling/"},{"categories":["åŸºç¡€çŸ¥è¯†","è¯¾ç¨‹"],"content":"I. Why MD vs Why QC MD Purpose: Study biological systems Calculate with function of time Predict and explain outcomes of biological experiments QC Purpose: No additional parameters required In theory, everything can be calculated ","date":"2025-03-28","objectID":"/zh-cn/advanced-modelling/:8:1","tags":["åŒ–å­¦ä¿¡æ¯å­¦","è®¡ç®—è¯ç‰©åŒ–å­¦","Pharameutical Modelling"],"title":"ä¹Œæ™®è¨æ‹‰å¤§å­¦ Advanced Molecular Modelling Applied to Drug Discovery(3FK181) è¯¾ç¨‹å¤ä¹ ç¬”è®°","uri":"/zh-cn/advanced-modelling/"},{"categories":["åŸºç¡€çŸ¥è¯†","è¯¾ç¨‹"],"content":"II. MD Approximation vs QC Postulates MD Approximations: Ignore electron motion Separate electron and nuclei Use Newtonâ€™s law Transfer parameters from small to large molecules QC Postulates: Wavefunction Î¨(r,t), Bornâ€™s interpretation (è§£é‡Š) For every observation, an operator For every operator, eigenvalues SchrÃ¶dingerâ€™s equation ","date":"2025-03-28","objectID":"/zh-cn/advanced-modelling/:8:2","tags":["åŒ–å­¦ä¿¡æ¯å­¦","è®¡ç®—è¯ç‰©åŒ–å­¦","Pharameutical Modelling"],"title":"ä¹Œæ™®è¨æ‹‰å¤§å­¦ Advanced Molecular Modelling Applied to Drug Discovery(3FK181) è¯¾ç¨‹å¤ä¹ ç¬”è®°","uri":"/zh-cn/advanced-modelling/"},{"categories":["åŸºç¡€çŸ¥è¯†","è¯¾ç¨‹"],"content":"III. Force Field Advantages/Disadvantages Force Field is simplified and empirical (ç»éªŒä¸Š) Form and parameters differ in different models Usefulness depends on questions asked Major problem: bonds cannot be broken Transferability of parameters unclear Polarization not considered General methods still developing ","date":"2025-03-28","objectID":"/zh-cn/advanced-modelling/:8:3","tags":["åŒ–å­¦ä¿¡æ¯å­¦","è®¡ç®—è¯ç‰©åŒ–å­¦","Pharameutical Modelling"],"title":"ä¹Œæ™®è¨æ‹‰å¤§å­¦ Advanced Molecular Modelling Applied to Drug Discovery(3FK181) è¯¾ç¨‹å¤ä¹ ç¬”è®°","uri":"/zh-cn/advanced-modelling/"},{"categories":["åŸºç¡€çŸ¥è¯†","è¯¾ç¨‹"],"content":"IV-V. MD Simulation Process Try to calculate the path of each individual Newtonâ€™s law May have errors Add-up errors may be OK Calculate motion as function of time ","date":"2025-03-28","objectID":"/zh-cn/advanced-modelling/:8:4","tags":["åŒ–å­¦ä¿¡æ¯å­¦","è®¡ç®—è¯ç‰©åŒ–å­¦","Pharameutical Modelling"],"title":"ä¹Œæ™®è¨æ‹‰å¤§å­¦ Advanced Molecular Modelling Applied to Drug Discovery(3FK181) è¯¾ç¨‹å¤ä¹ ç¬”è®°","uri":"/zh-cn/advanced-modelling/"},{"categories":["åŸºç¡€çŸ¥è¯†","è¯¾ç¨‹"],"content":"VI. Limits of MD Parameters not perfect Phase space not fully sampled Limited polarization effects (æåŒ–æ•ˆæœ) ","date":"2025-03-28","objectID":"/zh-cn/advanced-modelling/:8:5","tags":["åŒ–å­¦ä¿¡æ¯å­¦","è®¡ç®—è¯ç‰©åŒ–å­¦","Pharameutical Modelling"],"title":"ä¹Œæ™®è¨æ‹‰å¤§å­¦ Advanced Molecular Modelling Applied to Drug Discovery(3FK181) è¯¾ç¨‹å¤ä¹ ç¬”è®°","uri":"/zh-cn/advanced-modelling/"},{"categories":["åŸºç¡€çŸ¥è¯†","è¯¾ç¨‹"],"content":"VII. QC Approaches SchrÃ¶dinger Equation: H(r,t) = EÎ¨(r,t) Pauli exclusion principle and Slater determinant With Slater determinant + Basis Set â†’ Hartree-Fock Using GTO, STO-nG models (STO-3G means STO approximated by 3 GTOs) Hartree-Fock uses mean-field approach, but electronsâ€™ interaction is correlated Post Hartree-Fock: CI, MPn Density Functional Theory: No need to solve SchrÃ¶dinger, only 3N DFT = E[Ï] = T_S[Ï] + E_ne[Ï] + J[Ï] + E_xc[Ï] DFT principle accurate; HF is not But we still donâ€™t know the expression of E_xc[Ï] Choose B3LYP/6-31G to balance quality and cost Semi-Empirical Method: Reduce number of functions/integrals Model PMx (x=3,6,7) Hessian Matrix: Contains all second derivatives For energy min: all eigenvalues positive For TS: one eigenvalue negative A second-order saddle point: two eigenvalues negative Also in spectroscopy: E_vib = â„(n+Â½)âˆš(k/Î¼) Isotope effect ","date":"2025-03-28","objectID":"/zh-cn/advanced-modelling/:8:6","tags":["åŒ–å­¦ä¿¡æ¯å­¦","è®¡ç®—è¯ç‰©åŒ–å­¦","Pharameutical Modelling"],"title":"ä¹Œæ™®è¨æ‹‰å¤§å­¦ Advanced Molecular Modelling Applied to Drug Discovery(3FK181) è¯¾ç¨‹å¤ä¹ ç¬”è®°","uri":"/zh-cn/advanced-modelling/"},{"categories":["åŸºç¡€çŸ¥è¯†","è¯¾ç¨‹"],"content":"Words List Electrostatic: ç”µåŠ› Ï€-stacking Halogen Bond London Dispersion: a è‰²æ•£åŠ› Pauli Repulsion: æ³¡åˆ©(æ’æ–¥) Entropic: ç†µçš„ Enclosure/Exposure: æš´éœ²å¤–è¡¨çš„æ™¯è±¡ Torsional Potential: æ‰­è½¬åŠ¿èƒ½ Ensemble Average: æ€»ä½“~ Ergodic hypothesis: éå†å‡è®¾ Ensemble average = Time average Trajectory: è½¨è¿¹ Implicit solvent model Canonical Ensembles: ç­‰æ¸© Isobaric Ensemble Postulate: å‡è®¾ Operator: ç®—å­ Eigenvalue: ç‰¹å¾å€¼ Spherical/Periodic ","date":"2025-03-28","objectID":"/zh-cn/advanced-modelling/:8:7","tags":["åŒ–å­¦ä¿¡æ¯å­¦","è®¡ç®—è¯ç‰©åŒ–å­¦","Pharameutical Modelling"],"title":"ä¹Œæ™®è¨æ‹‰å¤§å­¦ Advanced Molecular Modelling Applied to Drug Discovery(3FK181) è¯¾ç¨‹å¤ä¹ ç¬”è®°","uri":"/zh-cn/advanced-modelling/"},{"categories":["å­¦æœ¯","å‘è¡¨"],"content":"Sci Data | éè‚½ç±»å¤§ç¯åŒ–åˆç‰©æ¸—é€æ€§æ•°æ®åº“ ","date":"2025-01-03","objectID":"/zh-cn/db/:0:0","tags":["åŒ–å­¦ä¿¡æ¯å­¦"],"title":"Sci Data | éè‚½ç±»å¤§ç¯åŒ–åˆç‰©æ¸—é€æ€§æ•°æ®åº“","uri":"/zh-cn/db/"},{"categories":["å­¦æœ¯","å‘è¡¨"],"content":"å¯¼è¯» è¿‘æ—¥ï¼Œç‘å…¸ä¹Œæ™®è¨æ‹‰å¤§å­¦Jan Kihlberg è¯¾é¢˜ç»„åœ¨ Scientific Data å‘è¡¨äº†é¢˜ä¸ºA membrane permeability database for nonpeptidic macrocyclesçš„è®ºæ–‡ã€‚ä¹Œæ™®è¨æ‹‰å¤§å­¦åŒ–å­¦ç³»Vasanthanathan Poongavanam å‰¯æ•™æˆ (Docent) å’Œ Jan Kihlberg æ•™æˆä¸ºè®ºæ–‡å…±åŒé€šè®¯ä½œè€…ï¼Œç¡•å£«ç ”ç©¶ç”Ÿå†¯ç§‹å®ä¸ºè®ºæ–‡ç¬¬ä¸€ä½œè€…ï¼ŒDanjo De Chavezåšå£«ä¸ºå‚ä¸ä½œè€…ã€‚ Lipinskiç±»è¯äº”è§„åˆ™ä½œä¸ºä¸€ç§é«˜æ•ˆç­›é€‰ç±»è¯åˆ†å­çš„å®šé‡å‡†åˆ™ï¼Œè§„å®šäº†ç±»è¯åˆ†å­åº”å…·å¤‡çš„ç‰¹å¾ï¼šåˆ†å­é‡å°äº500ã€æ°¢é”®ç»™ä½“ä¸è¶…è¿‡5ä¸ªã€æ°¢é”®å—ä½“ä¸è¶…è¿‡10ä¸ªã€æ²¹æ°´åˆ†é…ç³»æ•°å¯¹æ•°å€¼ä¸è¶…è¿‡5ã€‚ç„¶è€Œï¼Œè¿‘æœŸç ”ç©¶è¡¨æ˜ï¼Œçº¦åŠæ•°ä¸äººç±»ç–¾ç—…ç›¸å…³çš„é¶ç‚¹éš¾ä»¥è¢«ä¼ ç»Ÿçš„ã€ç¬¦åˆäº”è§„åˆ™çš„å°åˆ†å­è¯ç‰©æ‰€å¹²é¢„ã€‚è™½ç„¶å¤§åˆ†å­ç”Ÿç‰©åˆ¶å‰‚ä¸ºæ­¤æä¾›äº†æ›¿ä»£æ–¹æ¡ˆï¼Œä½†ç”Ÿç‰©åˆ¶å‰‚æ— æ³•ç©¿é€ç»†èƒä¸”ä¸é€‚åˆå£æœç»™è¯ï¼Œè¿™é™åˆ¶äº†å…¶å¯¹è®¸å¤šç»†èƒå†…é¶ç‚¹çš„åº”ç”¨ä»·å€¼ã€‚ åœ¨LipinskiåŒ–å­¦ç©ºé—´ä¹‹å¤–çš„\"è¶…è¶Šäº”è§„åˆ™\"ï¼ˆbeyond Ro5ï¼ŒbRo5ï¼‰åŒ–å­¦ç©ºé—´ä¸­ï¼Œå¤§ç¯åŒ–åˆç‰©å› å…¶ç‹¬ç‰¹ä¼˜åŠ¿è€Œå¤‡å—å…³æ³¨ã€‚è¿™ç±»ç”±12ä¸ªåŠä»¥ä¸ŠåŸå­æ„æˆçš„å¤§ç¯ç»“æ„åŒ–åˆç‰©èƒ½å¤Ÿä¸ä¼ ç»Ÿéš¾æ²»é¶ç‚¹äº§ç”Ÿæœ‰æ•ˆç›¸äº’ä½œç”¨ã€‚ç„¶è€Œï¼Œå¤§ç¯åŒ–åˆç‰©åœ¨æº¶è§£åº¦ã€ç»†èƒæ¸—é€æ€§å’Œä»£è°¢ç¨³å®šæ€§ç­‰å…³é”®å£æœç”Ÿç‰©åˆ©ç”¨åº¦æŒ‡æ ‡æ–¹é¢ä»é¢ä¸´æŒ‘æˆ˜ã€‚ é‰´äºç»†èƒæ¸—é€æ€§çš„å®éªŒæµ‹å®šå¾€å¾€è€—æ—¶ä¸”æˆæœ¬é«˜æ˜‚ï¼Œè®¡ç®—æœºæ¨¡æ‹Ÿæ–¹æ³•æä¾›äº†æ›´å…·æˆæœ¬æ•ˆç›Šçš„é¢„æµ‹é€”å¾„ã€‚åœ¨æ­¤ç ”ç©¶ä¸­ï¼Œè¯¥è¯¾é¢˜ç»„é€šè¿‡æ”¶é›†ç§‘å­¦æ–‡çŒ®ã€ä¸“åˆ©å’Œç”Ÿç‰©æ´»æ€§æ•°æ®åº“çš„æ•°æ®ï¼Œå»ºç«‹äº†ä¸€ä¸ªç¬¦åˆFAIRåŸåˆ™ï¼ˆFindable, Accessible, Interoperable, and Reusableï¼Œå³å¯æŸ¥æ‰¾ã€å¯è®¿é—®ã€å¯äº’æ“ä½œã€å¯é‡ç”¨ï¼‰çš„å…¨é¢æ•°æ®åº“ï¼ŒåŒ…å«4216ä¸ªå¤§ç¯åŒ–åˆç‰©çš„5638æ¡ç»†èƒæ¸—é€æ€§å®éªŒæ•°æ®ã€‚è¯¥æ•°æ®åº“å¯ä½œä¸ºæœºå™¨å­¦ä¹ å’Œæ·±åº¦å­¦ä¹ é¢„æµ‹æ¨¡å‹çš„è®­ç»ƒæ•°æ®é›†ã€‚æ­¤å¤–ï¼Œè¯¥ç ”ç©¶å›¢é˜Ÿè¿˜å¼•å…¥äº†\"é…°èƒºæ¯”ç‡\"ï¼ˆAmide Ratio, ARï¼‰è¿™ä¸€åˆ›æ–°æ€§åˆ†å­æè¿°ç¬¦ï¼Œé¦–æ¬¡å®ç°äº†å¤§ç¯åŒ–åˆç‰©çš„å®šé‡åˆ†ç±»ã€‚è¿™ä¸€å…è´¹åœ¨çº¿èµ„æºå°†æ˜¾è‘—ä¿ƒè¿›æ–°å‹å¤§ç¯è¯ç‰©çš„å¼€å‘è®¾è®¡ã€‚ ","date":"2025-01-03","objectID":"/zh-cn/db/:1:0","tags":["åŒ–å­¦ä¿¡æ¯å­¦"],"title":"Sci Data | éè‚½ç±»å¤§ç¯åŒ–åˆç‰©æ¸—é€æ€§æ•°æ®åº“","uri":"/zh-cn/db/"},{"categories":["å­¦æœ¯","å‘è¡¨"],"content":"æ•°æ®æ”¶é›† ç ”ç©¶å›¢é˜Ÿä»ä¸‰ä¸ªä¸»è¦æ¥æºæ”¶é›†æ•°æ®:ç§‘å­¦æ–‡çŒ®ã€ä¸“åˆ©æ–‡çŒ®å’Œç»¼åˆæ€§åŒ–å­¦æ•°æ®åº“ã€‚é¦–å…ˆç ”ç©¶å›¢é˜Ÿåˆ©ç”¨PubMedå’ŒGoogle Scholar,ç»“åˆ\"macrocycle\"å’Œ â€œpermeability\"æˆ–è€…ç‰¹å®šçš„æ¸—é€æ€§æµ‹é‡æ¨¡å‹ï¼ˆPAMPAï¼ŒCaco-2ï¼Œ MDCK å’Œ RRCKï¼‰ä¸ºå…³é”®è¯è¿›è¡Œæ–‡çŒ®æ£€ç´¢ï¼Œå¹¶åˆ©ç”¨åŒæ ·çš„æ£€ç´¢æ–¹å¼åœ¨Google Patentsæœç´¢å¼•æ“æ”¶é›†æ¥è‡ªå‘æ˜ä¸“åˆ©çš„éè‚½ç±»å¤§ç¯åŒ–åˆç‰©çš„æ¸—é€æ€§æ•°æ®ã€‚é™¤æ­¤ä¹‹å¤–ï¼Œè¯¥å›¢é˜Ÿè¿˜ä½¿ç”¨äº†ChEMBLæ•°æ®åº“çš„å®˜æ–¹Pythonæ¥å£ï¼ˆChEMBL API Python clientï¼‰è¿›è¡Œè‡ªåŠ¨åŒ–æ‰¹é‡æ•°æ®æ”¶é›†ã€‚ä¸ºç¡®ä¿æ•°æ®è´¨é‡,ç ”ç©¶äººå‘˜å¯¹æ‰€æœ‰æ”¶é›†çš„æ•°æ®è¿›è¡Œäº†ä¸¥æ ¼çš„äººå·¥å®¡æŸ¥å’Œæ ‡å‡†åŒ–å¤„ç†,åŒ…æ‹¬åˆ é™¤æ··åˆç‰©å’Œæ— æœºç‰©ã€ç»“æ„æ ‡å‡†åŒ–ä»¥åŠæ•°æ®å•ä½ç»Ÿä¸€ç­‰æ­¥éª¤ã€‚ ","date":"2025-01-03","objectID":"/zh-cn/db/:2:0","tags":["åŒ–å­¦ä¿¡æ¯å­¦"],"title":"Sci Data | éè‚½ç±»å¤§ç¯åŒ–åˆç‰©æ¸—é€æ€§æ•°æ®åº“","uri":"/zh-cn/db/"},{"categories":["å­¦æœ¯","å‘è¡¨"],"content":"æ•°æ®åˆ†æ ","date":"2025-01-03","objectID":"/zh-cn/db/:3:0","tags":["åŒ–å­¦ä¿¡æ¯å­¦"],"title":"Sci Data | éè‚½ç±»å¤§ç¯åŒ–åˆç‰©æ¸—é€æ€§æ•°æ®åº“","uri":"/zh-cn/db/"},{"categories":["å­¦æœ¯","å‘è¡¨"],"content":"æ•°æ®åº“å„å­é¡¹åˆ†æ æœ€ç»ˆå»ºç«‹çš„æ•°æ®åº“åŒ…å«5638æ¡æ¥è‡ªä¸åŒå®éªŒæ–¹æ³•çš„è†œæ¸—é€æ€§æ•°æ®,å…¶ä¸­84%æ¥è‡ªç§‘å­¦æ–‡çŒ®ã€4%æ¥è‡ªä¸“åˆ©æ–‡çŒ®ã€11%æ¥è‡ªChEMBLæ•°æ®åº“ã€‚æ•°æ®åº“ä¸­çš„æ¸—é€æ€§æ•°æ®ä¸»è¦æ¥è‡ªäº”ç±»å®éªŒæ–¹æ³•ã€‚å…¶ä¸­PAMPAå æ¯”æœ€é«˜,è¾¾67%(3767æ¡),å€¼å¾—æ³¨æ„çš„æ˜¯91%çš„PAMPAæ¸—é€æ€§æ•°æ®æ¥è‡ªåŒä¸€ç¯‡æ–‡çŒ®ã€‚Caco-2ç»†èƒå®éªŒæ•°æ®å 26%(1502æ¡),åŒ…å«é¡¶ç«¯åˆ°åŸºåº•(PappAB)å’ŒåŸºåº•åˆ°é¡¶ç«¯(PappBA)ä¸¤ä¸ªæ–¹å‘çš„è¡¨è§‚æ¸—é€ç³»æ•°(Pappï¼‰,ä»¥åŠåŠ å…¥è½¬è¿ä½“æŠ‘åˆ¶å‰‚åçš„ç›¸åº”å€¼(PappAB+Inh. å’ŒPappBA+Inh.ï¼‰ã€‚é€šè¿‡è®¡ç®—å¤–æ’æ¯”(ER = Papp BA/Papp AB),å¯è¯„ä¼°åŒ–åˆç‰©æ˜¯å¦å­˜åœ¨ä¸»åŠ¨å¤–æ’ä»¥åŠå¤–æ’çš„ç¨‹åº¦ã€‚MDCKç»†èƒå®éªŒè´¡çŒ®äº†264æ¡æ•°æ®,ä¸»è¦ç”¨äºè¯„ä¼°è¢«åŠ¨å’Œä¸»åŠ¨è·¨è†œè½¬è¿ç‰¹æ€§ã€‚ ","date":"2025-01-03","objectID":"/zh-cn/db/:3:1","tags":["åŒ–å­¦ä¿¡æ¯å­¦"],"title":"Sci Data | éè‚½ç±»å¤§ç¯åŒ–åˆç‰©æ¸—é€æ€§æ•°æ®åº“","uri":"/zh-cn/db/"},{"categories":["å­¦æœ¯","å‘è¡¨"],"content":"åˆ†å­ç‰¹æ€§åˆ†æ ç ”ç©¶å›¢é˜Ÿå¯¹æ•°æ®åº“ä¸­çš„å¤§ç¯åŒ–åˆç‰©è¿›è¡Œäº†å…¨é¢çš„åˆ†å­æ€§è´¨åˆ†æã€‚é¦–å…ˆï¼Œåˆ©ç”¨ TMAPï¼ˆTree-MAPï¼‰å¯¹ä¸åŒæ¸—é€æ€§æ¨¡å‹æµ‹å¾—çš„åŒ–åˆç‰©æ•°æ®è¿›è¡Œäº†å¯è§†åŒ–åˆ†æã€‚å…¶æ¬¡ï¼Œç»Ÿè®¡ç»“æœæ˜¾ç¤ºï¼Œè™½ç„¶çº¦åŠæ•°åŒ–åˆç‰©çš„åˆ†å­é‡è¶…è¿‡ 500 Daï¼Œä½†å¤§å¤šæ•°åŒ–åˆç‰©åœ¨ææ€§ï¼ˆæ°¢é”®ç»™ä½“ HBDã€æ°¢é”®å—ä½“ HBAã€æ‹“æ‰‘ææ€§è¡¨é¢ç§¯ TPSAï¼‰å’Œè„‚æº¶æ€§ï¼ˆcLogPï¼‰æ–¹é¢ä»ç¬¦åˆ Lipinski è§„åˆ™çš„ç•Œé™ã€‚æ•°æ®åº“ä¸­çº¦ 9% çš„åŒ–åˆç‰©å±äºâ€™è¶…è¶Šäº”è§„åˆ™â€™ç©ºé—´ï¼Œè¿™äº›åˆ†å­å¯èƒ½åœ¨è°ƒèŠ‚éš¾æ²»é¶ç‚¹æ–¹é¢å…·æœ‰ç‹¬ç‰¹ä¼˜åŠ¿ã€‚ ","date":"2025-01-03","objectID":"/zh-cn/db/:3:2","tags":["åŒ–å­¦ä¿¡æ¯å­¦"],"title":"Sci Data | éè‚½ç±»å¤§ç¯åŒ–åˆç‰©æ¸—é€æ€§æ•°æ®åº“","uri":"/zh-cn/db/"},{"categories":["å­¦æœ¯","å‘è¡¨"],"content":"è‚½ç±»ä¸éè‚½ç±»å¤§ç¯åŒ–åˆç‰©çš„åˆ’åˆ† åœ¨æ­¤ä¹‹å‰ï¼Œå­¦ç•Œä¸€ç›´ç¼ºä¹ä¸€ä¸ªæ ‡å‡†åŒ–çš„å®šé‡æŒ‡æ ‡æ¥æè¿°å¤§ç¯åŒ–åˆç‰©çš„è‚½ç±»ç‰¹å¾ã€‚ä¸ºè§£å†³è¿™ä¸€é—®é¢˜ï¼Œç ”ç©¶å›¢é˜Ÿæå‡ºäº†\"é…°èƒºæ¯”ç‡â€(AR)è¿™ä¸€å…¨æ–°çš„åˆ†å­æè¿°ç¬¦ã€‚é¦–å…ˆè€ƒè™‘å¤§ç¯ä¸­çš„é…°èƒºé”®æ•°é‡(Number of Amide Bond, nAB)ï¼Œæ¯ä¸ªé…°èƒºé”®ï¼ˆåŒ…æ‹¬æ™®é€šçš„NH-é…°èƒºé”®å’ŒN-çƒ·åŸºåŒ–çš„é…°èƒºé”®ï¼‰éƒ½ç”±ä¸‰ä¸ªåŸå­(-C-N-CÎ±-)æ„æˆã€‚ ç„¶åå°†ä¸Šè¿°ç»“æœé™¤ä»¥å¤§ç¯çš„ç¯å¤§å°(Macrocycle Ring Size, MRS)ï¼Œå³å¤§ç¯ä¸­æ‰€æœ‰åŸå­çš„æ€»æ•°ã€‚æ•…ARçš„è®¡ç®—å…¬å¼ä¸ºï¼šAR = (nAB Ã— 3)/MRS åŸºäºARå€¼çš„åˆ†å¸ƒç‰¹å¾,å¤§ç¯åŒ–åˆç‰©å¯åˆ†ä¸ºä¸‰ç±»:éè‚½ç±»(AR \u003c 0.3)ã€åŠè‚½ç±»(0.3 â‰¤ AR â‰¤ 0.7)å’Œè‚½ç±»(AR \u003e 0.7)ã€‚PCAï¼ˆPrincipal component analysisï¼Œä¸»æˆåˆ†åˆ†æï¼‰ç»“æœéªŒè¯äº†è¿™ä¸€åˆ†ç±»æ–¹æ³•çš„åˆç†æ€§,ä¸åŒç±»å‹çš„åŒ–åˆç‰©åœ¨åŒ–å­¦ç©ºé—´ä¸­å‘ˆç°å‡ºæ˜æ˜¾çš„åˆ†å¸ƒå·®å¼‚ã€‚ ","date":"2025-01-03","objectID":"/zh-cn/db/:3:3","tags":["åŒ–å­¦ä¿¡æ¯å­¦"],"title":"Sci Data | éè‚½ç±»å¤§ç¯åŒ–åˆç‰©æ¸—é€æ€§æ•°æ®åº“","uri":"/zh-cn/db/"},{"categories":["å­¦æœ¯","å‘è¡¨"],"content":"ç½‘é¡µæ•°æ®åº“ ç ”ç©¶å›¢é˜Ÿå¼€å‘äº†åŠŸèƒ½å®Œå–„çš„åœ¨çº¿æ•°æ®åº“å¹³å°(https://swemacrocycledb.com/)ã€‚åœ¨æµè§ˆæ¨¡å—ä¸­ï¼Œç”¨æˆ·å¯ä»¥æ ¹æ®åˆ†å­å”¯ä¸€IDã€åç§°ã€å®éªŒæ¨¡å‹ç±»å‹ã€åˆ†å­é‡ç­‰å•ä¸ªæˆ–ç»„åˆæ¡ä»¶ç­›é€‰æ„Ÿå…´è¶£çš„æ•°æ®é›†ï¼Œå¹¶ä»¥CSVæ ¼å¼å¯¼å‡ºã€‚å½“ç”¨æˆ·ç‚¹å‡»ç‰¹å®šåˆ†å­IDæ—¶ï¼Œç³»ç»Ÿä¼šåœ¨æ–°çª—å£ä¸­æ˜¾ç¤ºè¯¥åˆ†å­çš„è¯¦ç»†ä¿¡æ¯ï¼ŒåŒ…æ‹¬åç§°ã€ç»“æ„ã€æ¸—é€æ€§æ•°æ®å’Œåˆ†å­æè¿°ç¬¦ï¼ŒåŒæ—¶å±•ç¤ºè¯¥åˆ†å­çš„æ‰€æœ‰å¯ç”¨æ¸—é€æ€§æ•°æ®ï¼Œä»¥åŠå…·æœ‰ç›¸åŒ\"å¤§ç¯éª¨æ¶\"çš„ç±»ä¼¼åŒ–åˆç‰©æ¸…å•ï¼Œè¿™æœ‰åŠ©äºç”¨æˆ·æ¢ç´¢ç»“æ„ç›¸å…³åˆ†å­ã€‚åœ¨ä¸‹è½½æ¨¡å—ä¸­ï¼Œç”¨æˆ·å¯ä»¥ä¸‹è½½å®Œæ•´æ•°æ®é›†æˆ–è‡ªå®šä¹‰ç­›é€‰çš„æ•°æ®å­é›†ï¼Œå¯¼å‡ºçš„CSVæ–‡ä»¶ä¸ä»…åŒ…å«åˆ†å­ç»“æ„ã€ç»†èƒæ¸—é€æ€§æ•°æ®å’Œåˆ†å­æè¿°ç¬¦ï¼Œè¿˜æä¾›åˆ†å­çš„è‚½ç±»ç‰¹å¾åˆ†ç±»å’ŒåŸå§‹æ•°æ®æ¥æºä¿¡æ¯ã€‚åœ¨ç»Ÿè®¡æ¨¡å—ä¸­ï¼Œå¹³å°æ”¯æŒå¯¹æ•´ä½“æ•°æ®é›†åŠä¸‰ä¸ªä¸»è¦æ¸—é€æ€§å­é›†çš„ç»†èƒæ¸—é€æ€§æ•°æ®å’Œåˆ†å­æè¿°ç¬¦è¿›è¡Œç»Ÿè®¡åˆ†æï¼Œå¹¶æä¾›ç›´è§‚çš„æ•°æ®å¯è§†åŒ–å±•ç¤ºã€‚è¿™äº›åŠŸèƒ½çš„æœ‰æœºç»“åˆä½¿å¾—è¯¥æ•°æ®åº“ä¸ä»…æ–¹ä¾¿ç”¨æˆ·æŸ¥æ‰¾å’Œè·å–æ‰€éœ€æ•°æ®ï¼Œè¿˜èƒ½å¸®åŠ©ç”¨æˆ·æ·±å…¥ç†è§£å¤§ç¯åŒ–åˆç‰©çš„ç»“æ„-æ€§è´¨å…³ç³»ï¼Œä¸ºè¯ç‰©è®¾è®¡æä¾›æœ‰åŠ›æ”¯æŒã€‚ ","date":"2025-01-03","objectID":"/zh-cn/db/:4:0","tags":["åŒ–å­¦ä¿¡æ¯å­¦"],"title":"Sci Data | éè‚½ç±»å¤§ç¯åŒ–åˆç‰©æ¸—é€æ€§æ•°æ®åº“","uri":"/zh-cn/db/"},{"categories":["å­¦æœ¯","å‘è¡¨"],"content":"è®¨è®ºä¸å‰ç» ç„¶è€Œï¼Œè¯¥æ•°æ®åº“ç›®å‰ä»å­˜åœ¨ä¸€äº›å±€é™æ€§ã€‚é¦–å…ˆï¼Œç”±äºç¼ºä¹å¯é çš„è®¡ç®—æ–¹æ³•æ¥å¤„ç†ç»“æ„å¤šæ ·çš„å¤§ç¯åŒ–åˆç‰©ï¼Œç›®å‰æ•°æ®åº“ä¸­å¹¶æœªåŒ…å«3Dç»“æ„ä¿¡æ¯å’Œ3Dåˆ†å­ç‰¹å¾ã€‚æ­¤å¤–ï¼Œæ•°æ®æ”¶é›†æˆªæ­¢äº2023å¹´7æœˆï¼Œè¿™æ„å‘³ç€ä¹‹åå‘è¡¨çš„ç›¸å…³ç ”ç©¶æ•°æ®å°šæœªè¢«æ”¶å½•ã€‚ä¸ºè§£å†³è¿™äº›é—®é¢˜ï¼Œç ”ç©¶å›¢é˜Ÿè®¡åˆ’å®šæœŸæ›´æ–°æ•°æ®åº“å†…å®¹ï¼Œå¹¶åœ¨ç½‘ç«™è¿è¡ŒååŠæ—¶ä¿®æ­£å‘ç°çš„é”™è¯¯ã€‚æ€»è€Œè¨€ä¹‹ï¼Œè¯¥ç ”ç©¶ä¸ºä»äº‹å¤§ç¯åŒ–åˆç‰©ç ”ç©¶çš„ç§‘ç ”äººå‘˜æä¾›äº†å®è´µçš„å‚è€ƒèµ„æºï¼ŒåŒæ—¶è¿˜æå‡ºäº†ä¸€ç§æ”¶é›†å’Œæ•´ç†ç”Ÿç‰©æ´»æ€§æ•°æ®çš„æ–¹æ³•è®ºï¼Œä»è€Œå……åˆ†å‘æŒ¥æœºå™¨å­¦ä¹ æ–¹æ³•åœ¨è¯ç‰©ç ”å‘é¡¹ç›®ä¸­çš„æ½œåŠ›ã€‚ ","date":"2025-01-03","objectID":"/zh-cn/db/:5:0","tags":["åŒ–å­¦ä¿¡æ¯å­¦"],"title":"Sci Data | éè‚½ç±»å¤§ç¯åŒ–åˆç‰©æ¸—é€æ€§æ•°æ®åº“","uri":"/zh-cn/db/"},{"categories":["å­¦æœ¯","å‘è¡¨"],"content":"è¯¾é¢˜ç»„ç®€ä»‹ ç‘å…¸ä¹Œæ™®è¨æ‹‰å¤§å­¦Jan Kihlberg è¯¾é¢˜ç»„é•¿æœŸè‡´åŠ›äºæ¢ç´¢ä¼ ç»Ÿè¯ç‰©é¢†åŸŸä¹‹å¤–çš„ç ”ç©¶å’Œè¯ç‰©å‘ç°ã€‚è¯¥è¯¾é¢˜ç»„ç‰¹åˆ«å…³æ³¨çªç ´ä¼ ç»Ÿ Lipinski ç±»è¯äº”è§„åˆ™çš„é™åˆ¶ï¼Œæ¢ç´¢æ–°çš„åŒ–å­¦ç©ºé—´ã€‚ç ”ç©¶å‘ç°è¿™ç±»åŒ–åˆç‰©å…·æœ‰ç‹¬ç‰¹çš„ç»†èƒæ¸—é€æ€§å’Œå£æœç”Ÿç‰©åˆ©ç”¨åº¦ç‰¹å¾ã€‚è¯¥è¯¾é¢˜ç»„åœ¨åˆ†å­æ„è±¡çµæ´»æ€§å’Œæ°¢é”®è°ƒæ§æ–¹é¢å–å¾—é‡è¦çªç ´ï¼Œä¸ºè¯ç‰©ç ”å‘æä¾›äº†æ–°æ€è·¯ã€‚è¯¥è¯¾é¢˜ç»„åœ¨è¯¥é¢†åŸŸå‘è¡¨çš„å¼€åˆ›æ€§è®ºæ–‡ï¼ˆJ. Med. Chem. 2014, 57, 278-295ï¼‰å·²è·å¾—å¹¿æ³›å¼•ç”¨å’Œè®¤å¯ã€‚ å‚è€ƒèµ„æ–™ Feng, Q., De Chavez, D., Kihlberg, J. et al. A membrane permeability database for nonpeptidic macrocycles. Sci Data 12, 10 (2025). https://doi.org/10.1038/s41597-024-04302-z ","date":"2025-01-03","objectID":"/zh-cn/db/:6:0","tags":["åŒ–å­¦ä¿¡æ¯å­¦"],"title":"Sci Data | éè‚½ç±»å¤§ç¯åŒ–åˆç‰©æ¸—é€æ€§æ•°æ®åº“","uri":"/zh-cn/db/"},{"categories":["å­¦æœ¯"],"content":"å‰è¨€ é²è¿…å…ˆç”Ÿæ›¾ç»è¯´è¿‡ï¼šå‘åŒ–å­¦æ–‡ç« ä¸ç»™SMILESç­‰äºæ²¡æœ‰å‘è¿‡ã€‚é²è¿…ï¼šæˆ‘æ²¡è¯´è¿‡ ä½†æ˜¯å¾ˆå¤šæ–‡ç« é‡Œé¢çš„åŒ–å­¦ç»“æ„çš„Supporting Information é‡Œé¢ç¡®å®ä¸ç»™SMILESã€‚æ¶‰åŠåˆ°å…¨åˆæˆæˆ–è€…ä¸€å¤§å †æ‰‹æ€§çš„åŒ–åˆç‰©å¦‚æœæˆ‘ä»¬æƒ³è¦è‡ªå·±åœ¨ChemDrawé‡Œé¢ç”»å‡ºæ¥å°±æåº¦ç—›è‹¦ã€‚ InDraw for web æ˜¯ä¸€ä¸ªåœ¨çº¿åŒ–å­¦ç»“æ„å¼ç»˜åˆ¶è½¯ä»¶ï¼Œæœ€ç‰›Xçš„æ˜¯ä»–å¯ä»¥æŠŠåŒ–å­¦å›¾ç‰‡ç»“æ„å¼è¯†åˆ«æˆSMILESï¼ˆæˆ–è€…å…¶ä»–è½¯ä»¶å¯è¯»ï¼‰çš„æ ¼å¼ã€‚ ","date":"2024-08-12","objectID":"/zh-cn/structure-ocr/:0:1","tags":["é»‘ç§‘æŠ€","åŒ–å­¦ä¿¡æ¯å­¦"],"title":"InDraw: ç”¨AIæŠŠåŒ–å­¦ç»“æ„å›¾ç‰‡è½¬æ¢æˆSMILES","uri":"/zh-cn/structure-ocr/"},{"categories":["å­¦æœ¯"],"content":"å®ä¾‹ å¤åˆ¶ä¸€å¼ çœ‹èµ·æ¥å°±å¾ˆåŠé€€çš„ç»“æ„å¼å›¾ç‰‡ï¼Œé»è´´åœ¨ç”»æ¿é‡Œé¢ã€‚é€‰æ‹© AI å›¾åƒè¯†åˆ« è¯†åˆ«å®Œæˆåï¼Œå³é”®ï¼Œé€‰æ‹©æƒ³è¦çš„æ ¼å¼ï¼Œæå®šï¼ æ³¨æ„ âš ï¸ åœ¨ä½¿ç”¨ä¹‹å‰åŠ¡å¿…äººå·¥æ ¡å¯¹ï¼ ç”¨äºè¯†åˆ«çš„å›¾ç‰‡å¹¶éå°ºå¯¸è¶Šå¤§è¶Šå¥½ï¼Œä¿è¯èƒŒæ™¯å¹²å‡€å°±è¡Œã€‚ ","date":"2024-08-12","objectID":"/zh-cn/structure-ocr/:0:2","tags":["é»‘ç§‘æŠ€","åŒ–å­¦ä¿¡æ¯å­¦"],"title":"InDraw: ç”¨AIæŠŠåŒ–å­¦ç»“æ„å›¾ç‰‡è½¬æ¢æˆSMILES","uri":"/zh-cn/structure-ocr/"},{"categories":["å­¦æœ¯"],"content":"å‰è¨€ ChEMBL ç®—æ˜¯å„ä½åŒ–å­¦ä»ä¸šè€…å–œé—»ä¹è§çš„æ•°æ®åº“ã€‚ï¼ˆå› ä¸ºä»–ä¸è¦é’±ï¼‰ ä½†æ˜¯å¦‚æœæˆ‘ä»¬æƒ³è¦æ‰¹é‡æ”¶é›†æˆ‘ä»¬æƒ³è¦çš„å†…å®¹ï¼Œç”¨ç½‘é¡µç‰ˆæŒ¨ä¸ªå¯»æ‰¾å±å®æœ‰ç‚¹éº»çƒ¦äº†ã€‚é‚£ä¹ˆï¼Œæœ‰æ²¡æœ‰ä»€ä¹ˆæ–¹æ³•èƒ½å¤Ÿæ‰¹é‡ ä¸”è‡ªåŠ¨è·å–æˆ‘ä»¬æƒ³è¦çš„åˆ†å­ä¿¡æ¯å‘¢ï¼Ÿ å…¶å®é™¤äº†æˆ‘ä»¬ç†ŸçŸ¥çš„ChEMBLç½‘é¡µ ï¼Œ ChEMBL è¿˜è´´å¿ƒçš„æä¾›äº†å¯ä»¥ç”¨Python æœç´¢çš„ ChEMBL web service client æœåŠ¡ã€‚åªè¦æˆ‘ä»¬åœ¨Pythonä»£ç ä¸­è¾“å…¥æƒ³è¦çš„å…³é”®è¯ï¼Œå°±å¯ä»¥æ‰¹é‡æœç´¢åˆ°æˆ‘ä»¬æƒ³è¦çš„å†…å®¹ç„¶åä¿å­˜ä¸ºCSV æ–‡ä»¶ç”¨äºåç»­å¤„ç†ã€‚ï¼ˆæ¯”å¦‚èµ›åšç‚¼ä¸¹ï¼‰ åº”ç”¨å®ä¾‹ ä¸€ä½åŠ±å¿—å‘JACSçš„åŒå­¦å¸Œæœ›æ”¶é›†ChEMBLä¸Šæ‚ç¯åŒ–åˆç‰©Heterocyclic compoundçš„ æº¶è§£åº¦Solubilityæ•°æ®ï¼Œæˆ‘ä»¬åº”è¯¥æ€ä¹ˆæ‰¾å‘¢ï¼Ÿ ç¤ºä¾‹ä»£ç ï¼š é¦–å…ˆ å®‰è£…chembl_webresource_client åŒ… ! pip install chembl_webresource_client ç„¶åè¿è¡Œè¿™ä¸€æ®µä»£ç  import csv from chembl_webresource_client.new_client import new_client # æ–°å»ºä¸€ä¸ªClient client = new_client # å½•å…¥å…³é”®è¯ solubility assays = client.assay.filter( description__icontains='solubility' ) # æ–°å»ºä¸€ä¸ªCSVæ–‡ä»¶å­˜å‚¨ç»“æœ with open('heterocyclic_solubility_data.csv', 'w', newline='', encoding='utf-8') as csvfile: fieldnames = ['CHEMBL_ID', 'SMILES', 'Solubility_value', 'Solubility_units', 'Solubility_doi', 'Assay_description'] # è¿™é‡Œæˆ‘ä»¬æ‰“ç®—æ”¶é›†æ‚ç¯åˆ†å­çš„ IDï¼ŒSMILESç»“æ„å¼ï¼Œæº¶è§£åº¦æ•°æ®å’Œå•ä½ï¼ŒåŸå§‹æ–‡çŒ®å’Œè¿™ä¸ªæ•°æ®çš„è¯´æ˜ï¼ˆæ¯”å¦‚æµ‹è¯•æ¡ä»¶ï¼‰ï¼Œä¸éœ€è¦çš„è¯å¯ä»¥æŒ‰éœ€åˆ é™¤ writer = csv.DictWriter(csvfile, fieldnames=fieldnames) writer.writeheader() for assay in assays: activities = client.activity.filter(assay_chembl_id=assay['assay_chembl_id']) for activity in activities: try: molecule = client.molecule.get(activity['molecule_chembl_id']) # åˆ¤æ–­è¿™ä¸ªåˆ†å­æ˜¯ä¸æ˜¯æ‚ç¯åˆ†å­ is_heterocyclic = False if molecule.get('molecule_structures'): smiles = molecule['molecule_structures'].get('canonical_smiles') if smiles and any(atom in smiles for atom in ['n', 'o', 's', 'p','se']): is_heterocyclic = True if is_heterocyclic: try: document = client.document.get(activity['document_chembl_id']) doi = document.get('doi', \"Not Available\") except Exception: doi = \"Not Available\" # å‚¨å­˜ç»“æœ writer.writerow({ 'CHEMBL_ID': activity['molecule_chembl_id'], 'SMILES': smiles, 'Solubility_value': activity.get('value', \"Not Available\"), 'Solubility_units': activity.get('units', \"Not Available\"), 'Solubility_doi': doi, 'Assay_description': assay.get('description', \"Not Available\") }) except Exception as e: print(f\"Error processing molecule {activity['molecule_chembl_id']}: {str(e)}\") continue print(\"Data collection completed. Results saved in 'heterocyclic_solubility_data.csv'.\") ç„¶åæˆ‘ä»¬å°±èƒ½çœ‹åˆ°æˆ‘ä»¬æƒ³è¦çš„ç»“æœäº† æ³¨æ„äº‹é¡¹ ChEMBL ä¸Šé¢çš„æ•°æ®å‡ä¸ºäººè‚‰æ”¶é›†å’Œå½•å…¥ï¼Œè¯·åŠ¡å¿…ä½¿ç”¨ä¹‹å‰äººå·¥éªŒè¯ è¿™ä¸€ä¸ªè¿‡ç¨‹å¯èƒ½æŒç»­å¾ˆé•¿ä¸€æ®µæ—¶é—´ï¼Œå»ºè®®åœ¨ç¨‹åºè¿è¡Œè¿‡ç¨‹ä¸­å¤šå¤šæ‘¸é±¼ Good Luckï¼ å‚è€ƒæ–‡çŒ®ï¼šDavies et al.,2015 ","date":"2024-08-11","objectID":"/zh-cn/chembl/:0:1","tags":["åŒ–å­¦ä¿¡æ¯å­¦"],"title":"ä½¿ç”¨ChEMBL Python API æœç´¢åŒ–åˆç‰©ä¿¡æ¯","uri":"/zh-cn/chembl/"},{"categories":["å­¦æœ¯"],"content":"å‰è¨€ ç¬”è€…å‘ç°ä¼ ç»Ÿçš„ç”¨RDKitç”»å›¾ç”»å‡ºæ¥æœ‰ç™½è‰²èƒŒæ™¯ï¼Œæ”¾åœ¨PowerPointé‡Œé¢å¾ˆä¸çˆ½ã€‚å‚è€ƒäº†è¿™ä¸€ç¯‡æ–‡çŒ®æ‰¾åˆ°äº†ä»£ç ã€‚ from rdkit import Chem from rdkit import rdBase from rdkit.Chem import Draw from rdkit.Chem.Draw import rdMolDraw2D from rdkit.Chem import rdDepictor rdDepictor.SetPreferCoordGen(True) from rdkit.Chem import rdMolDescriptors from rdkit.Chem import rdFMCS from rdkit import DataStructs import io from PIL import Image def show_png(data): bio = io.BytesIO(data) img = Image.open(bio) return img smi = \"CCCCCC\" #ä»¥ç¯å·±çƒ·ä¸ºä¾‹ drawer = rdMolDraw2D.MolDraw2DCairo(300,300) #å¯ä»¥è‡ªè¡Œè°ƒæ•´å›¾åƒå°ºå¯¸ drawer.drawOptions().clearBackground = False drawer.drawOptions().addStereoAnnotation = False drawer.DrawMolecule(Chem.MolFromSmiles(smi)) drawer.FinishDrawing() mol = drawer.GetDrawingText() show_png(mol) å³é”®ä¿å­˜å³å¯å¾—åˆ°é€æ˜çš„pngæ–‡ä»¶ã€‚ ","date":"2024-08-05","objectID":"/zh-cn/transparent/:0:0","tags":["åŒ–å­¦ä¿¡æ¯å­¦"],"title":"ä½¿ç”¨RDKitç”Ÿæˆæ— èƒŒæ™¯çš„åŒ–å­¦ç»“æ„å¼--é™„Pythonä»£ç ","uri":"/zh-cn/transparent/"}]